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ABSTRACT
Over the past decade, there has been an exponential growth in products
and applications that utilize nanotechnology, as these materials present exciting
opportunities for the development of new products, enhancement of existing
products, and the evolution of innovative procedures. However, this recent
growth has occurred in the absence of detailed knowledge concerning the
interactions of nanoparticles with biological systems. Nanoparticles must usually
be bioavailable in order to elicit a biological response, and to reach an active site
they must usually cross a membrane.

As a result, cell culture studies have

proven to be beneficial and are generally one of the first tests conducted upon
the synthesis of a new particle type. Furthermore, the development of in vitro
assays to predict biological interactions with nanoparticles may facilitate future
endeavors towards accurate assessments of the risk that nanoparticles may
pose on the environment. The goal of my dissertation was to characterize the
uptake of gold nanoparticles by the mammalian cell line A549 through
determining the roles of particle characteristics and culture medium components,
and by describing potential modes by which particles are endocytosed.

To

assess the influence of the physical and chemical characteristics of gold
nanospheres on cell uptake, a semi-factorial design was followed, examining
three different particle sizes (roughly 5nm, 15nm and 50nm) modified by three
different surface charges (anionic, cationic, and nonionic). The influence of
particle concentration on cellular uptake was analyzed for 5nm and 50nm citrate-
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capped spheres over 24 h, and particle uptake increased as exposure
concentration increased. The influence of particle size and surface charge on
uptake was analyzed for each particle type over 2 h, and with the exception of
50nm nonionic particles, uptake was charge dependent; as cationic particles
were taken up to a greater extent than anionic particles, which were taken up
more than nonionic particles. To assess the influence of the culture medium
components on particle uptake, cells were exposed to 30nm citrate-capped
particles in exposure media supplemented with differing concentrations of fetal
bovine serum (FBS) and bovine serum albumin (BSA). The uptake of particles
exposed in FBS was inversely related to protein exposure concentration, which
was not observed with particles in media supplemented with BSA, suggesting
that certain components of FBS deter particle uptake. When cells were exposed
to particles in media supplemented charcoal/dextran treated FBS, particle uptake
increased significantly suggesting that growth factors and steroids may inhibit
particle uptake. When cells were exposed to particles in media supplemented
with BSA in addition to fetuin, uptake decreased significantly suggesting that
fetuin may deter particle uptake. Also, particle uptake decreased when calcium
was removed from the exposure media, suggesting that uptake occurs through a
calcium dependent process. To assess potential modes of endocytosis utilized in
the cellular trafficking of nanoparticles, cells were co-exposed to 30nm citratecapped nanospheres and known inhibitors of specific endocytic pathways. Filipin
and

nystatin

were

used

to

inhibit
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caveolae-dependent

endocytosis,

chlorpromazine and phenylarsine oxide to inhibit clathrin-dependent endocytosis,
and cytochalasin D and 5-(N-ethyl-N-Isopropyl) amiloride (EIPA) were utilized to
inhibit macropinocytosis. No statistical decrease in particle uptake, in comparison
to controls, was observed following exposure to any of the inhibitors, suggesting
that the uptake of nanoparticles was not dependent upon any one specific mode
of endocytosis. Overall, the results of my dissertation indicate that uptake is
dependent upon both characteristics of the particle and exposure medium, and
that the uptake of particles is a complex process which cannot be described
solely by pharmacological inhibition.

iv

DEDICATION
This work is dedicated to my parents, Dr. James Samuel Garner, IV and
Arden Thomas Garner. I could not have come this far without the guidance,
opportunities, love, and support that they have continually bestowed upon me for
my entire life. For this I will forever be grateful and will never be able to thank
them enough.

v

ACKNOWLEDGMENTS
I would like to begin by thanking Dr. Steve Klaine for giving me the
opportunity to work with him and further develop my skills as an environmental
toxicologist and as a person. I could not have asked for a better advisor, mentor,
colleague, or friend. I would also like to thank each of my committee members,
Dr. Bill Baldwin, Dr. Cindy Lee, Dr. Andy Mount, and Dr. Aaron Roberts, for the
support, guidance, time, and patience that they have given me over the years in
order to reach this milestone in my life.
I would also like to thank Norm Ellis and John Smink for their continued
support throughout my time here at Clemson. Norm was extremely helpful in my
analytical analysis, even under the tightest of deadlines when it required working
late nights and weekends, and both were always there to discuss science, life,
football, and all things between. I would have never made it this far without the
advice and support from all members of the Klaine Lab, past and present. I could
never ask for better colleagues and friends than those that I had here.
Specifically, I am forever indebted to Dr. Aaron Edgington, Dr. Brandon Seda, Dr.
Brad Glenn, and Austin Wray for furthering my knowledge on nanoparticles,
particle synthesis, particle characterization, and all other nano-related matter.
I must also thank Dr. Catherine Murphy and Dr. Christopher Kitchens, as
well as Ashley Hart and Scott Cole from the lab of Dr. Kitchens, for providing me
with the array of particles needed in the second chapter of my dissertation. This

vi

work could not have been completed without their collaboration. I would also like
to thank all the faculty members of the Environmental Toxicology Graduate
Program, Dr. Charlie Rice, Dr. Lisa Bain, and Dr, Kim Paul for always being there
to answer any questions and offer suggestions and advice for my work. Also, my
cell culture work could never have gone as smoothly without the help of Dr. GiaMing Hong, Ben Green, Amy Anderson, Lauren Sweet, and Jui-Tung “Ray” Liu.
I always tell Mrs. Francis Atkinson that everything I ever needed to know, I
learned in kindergarten. As this is not completely true, I must also thank each
and every teacher that I have had along the way, for I know that I was no simple
pupil. I would especially like to thank Susan Smith and Cynthia Collins for
teaching me to never accept anything short of excellence, as well as Bunny
Beeson, Robert Kirby, and Dr. Alix Darden for making science come to life, which
grabbed my heart and soul. I must thank Dr. John Weinstein for believing in me,
mentoring me, his wonderful friendship, and for causing me to realize my desired
path of study.
Finally, I would not have been able to make it this far without the
unconditional love of my family, friends, and Citadel brethren. I would like to
graciously thank my grandparents Dr. Jim and Mary Garner and J.B. and Lenora
Thomas, my parents Dr. Sandy and Arden Garner, my brother Jay Garner, my
god-brother Ryan Brewer, my sister-in-law Whitney Garner, my niece Pressley
Anne Garner, and my nephew Samuel Garner for their never-ending love and

vii

support. Especially to my grandfathers who, through their actions, taught me the
value of hard work and that it you do what you love, you will do it well and for a
lifetime. I must also thank Thomas Hunter, Daniel Isaac, and my brother for
always believing in me and pushing me when I no longer believed in myself, and
for being my best friends, as well as Thomas and my mother for making me
realize that “there’s something in these hills”. Finally, I must thank Dr. Anthony
Sowers, Dr. Holly Nance, Dr. Joe Bisesi, Dr. Louis Plough, Aileen Plough, Amy
Anderson, Cason Collins, Ira Harper, Jeremy Trammell, and The Sosebees for
their friendship, the wonderful memories, and making my time in Clemson an
amazing experience.

viii

TABLE OF CONTENTS
Page
TITLE PAGE .......................................................................................................... i
ABSTRACT ........................................................................................................... ii
DEDICATION ........................................................................................................ v
ACKNOWLEDGMENTS ...................................................................................... vi
TABLE OF CONTENTS .......................................................................................vii
LIST OF FIGURES ............................................................................................. xiii
LIST OF TABLES................................................................................................xvi
CHAPTER ONE: LITERATURE REVIEW: THE ENVIRONMENTAL
FATE AND EFFECTS OF ENGINEERED NANOPARTICLES ........................ 1
Introduction ................................................................................................ 1
Nanoparticle Fate in the Environment ........................................................ 3
Nanoparticle Uptake In Vivo ....................................................................... 5
Nanoparticle Uptake In Vitro ...................................................................... 9
Research Needs and Conclusions ........................................................... 13
References ............................................................................................... 15
CHAPTER TWO: THE INFLUENCE OF PARTICLE SIZE
AND SURFACE CHEMISTRY ON THE CELLULAR
UPTAKE OF GOLD NANOPARTCLES ......................................................... 22
Abstract .................................................................................................... 22
Introduction .............................................................................................. 23
Materials and Methods ............................................................................. 25
Particle Synthesis .......................................................................... 25
Particle Characterization ............................................................... 27

ix

TABLE OF CONTENTS (cont.)
Page
Cell Culture .................................................................................... 27
Cell Exposures .............................................................................. 28
Influence of Particle Concentration ................................................ 29
Influence of Particle Characteristics .............................................. 29
Analytical Procedure...................................................................... 30
Data Analysis ................................................................................ 30
Results ..................................................................................................... 31
Particle Characterization ............................................................... 31
Influence of Particle Concentration ................................................ 32
Influence of Particle Characteristics .............................................. 35
Influence of Particle Size ............................................................... 38
Influence of Particle Surface Charge ............................................. 41
Size and Surface Effects ............................................................... 48
Discussion ................................................................................................ 50
Conclusions.............................................................................................. 52
References ............................................................................................... 54
CHAPTER THREE: NOVEL APPROACHES TO ELUCIDATE
SERUM COMPONENTS INVOLVED IN THE CELLULAR
UPTAKE OF NANOPARTICLES ................................................................... 58
Abstract .................................................................................................... 58
Introduction .............................................................................................. 59
Materials and Methods ............................................................................. 61
Particle Synthesis .......................................................................... 61
Particle Characterization ............................................................... 61
Cell Culture .................................................................................... 62
Cell Exposures .............................................................................. 63
FBS vs. BSA Supplementation ...................................................... 63
Phase I PIE ................................................................................... 64
Phase II PIE .................................................................................. 65
Influence of Calcium ...................................................................... 66
Analytical Procedure...................................................................... 66

x

TABLE OF CONTENTS (cont.)
Page
Data Analysis ................................................................................ 67
Results ..................................................................................................... 67
Particle Characterization ............................................................... 67
FBS vs. BSA Supplementation ...................................................... 68
Phase I PIE ................................................................................... 71
Phase II PIE .................................................................................. 74
Influence of Calcium ...................................................................... 80
Discussion ................................................................................................ 83
Conclusions.............................................................................................. 87
References ............................................................................................... 88
CHAPTER FOUR: EXAMINATION OF POTENTIAL
MODES OF NANOPARTICLE UPTAKE THROUGH
THE PHARMACOLOGICAL INHIBITION OF
ENDOCYTIC PATHWAYS ............................................................................ 93
Abstract .................................................................................................... 93
Introduction .............................................................................................. 94
Materials and Methods ............................................................................. 96
Particle Synthesis .......................................................................... 96
Particle Characterization ............................................................... 96
Cell Culture .................................................................................... 97
Cell Exposures .............................................................................. 98
Inhibition of Caveolae-Dependent Endocytosis ............................. 99
Inhibition of Clathrin-Dependent Endocytosis ................................ 99
Inhibition of Macropinocytosis ....................................................... 99
Analytical Procedure.................................................................... 100
Data Analysis .............................................................................. 100
Results ................................................................................................... 101
Particle Characterization ............................................................. 101
Inhibition of Caveolae-Dependent Endocytosis ........................... 101
Inhibition of Clathrin-Dependent Endocytosis .............................. 105
Inhibition of Macropinocytosis ..................................................... 109

xi

TABLE OF CONTENTS (cont.)
Page
Discussion .............................................................................................. 113
Conclusions............................................................................................ 115
References ............................................................................................. 117
CHAPTER FIVE: CONCLUSIONS AND
FUTURE RESEARCH ................................................................................. 120
APPENDIX I ...................................................................................................... 124
APPENDIX II ..................................................................................................... 135

xii

LIST OF FIGURES
Figure

Page

2.1

Influence of particle concentration on uptake for
5nm citrate-capped spheres ............................................................... 33

2.2

Influence of particle concentration on uptake for
50nm citrate-capped spheres ............................................................. 34

2.3

Uptake of citrate-capped spheres ............................................................ 36

2.4

Uptake of PEG-capped spheres............................................................... 37

2.5

Uptake of PEI-capped spheres ................................................................ 39

2.6

Influence of particle size on the uptake of
citrate-capped spheres ....................................................................... 40

2.7

Influence of particle size on the uptake of
PEG-capped spheres.......................................................................... 42

2.8

Influence of particle size on the uptake of
PEI-capped spheres ........................................................................... 43

2.9

Influence of particle surface charge on the
uptake of 5-6nm spheres .................................................................... 44

2.10

Influence of particle surface charge on the
uptake of 13-18nm spheres ................................................................ 46

2.11

Influence of particle surface charge on the
uptake of 50-55nm spheres ................................................................ 47

2.12

Influence of particle size and surface charge
on the uptake of gold nanoparticles .................................................... 49

3.1

Influence of FBS on the uptake of gold nanoparticles ............................. 69

3.2

Influence of BSA on the uptake of gold nanoparticles .............................. 70

3.3

Influence of iFBS on the uptake of gold nanoparticles
in comparison to FBS uptake .............................................................. 72

xiii

LIST OF FIGURES (cont.)
Figure

Page

3.4

Influence of dFBS on the uptake of gold nanoparticles
in comparison to FBS uptake .............................................................. 73

3.5

Influence of cFBS on the uptake of gold nanoparticles
in comparison to FBS uptake .............................................................. 75

3.6

Influence of aBSA on the uptake of gold nanoparticles
in comparison to BSA uptake.............................................................. 76

3.7

Influence of hBSA on the uptake of gold nanoparticles
in comparison to BSA uptake.............................................................. 78

3.8

Influence of tBSA on the uptake of gold nanoparticles
in comparison to BSA uptake.............................................................. 79

3.9

Influence of fBSA on the uptake of gold nanoparticles
in comparison to BSA uptake.............................................................. 81

3.10

Influence of calcium on the uptake of gold nanoparticles
in comparison to BSA uptake.............................................................. 82

4.1

Inhibition of caveolae-dependent endocytosis
when supplemented with FBS .......................................................... 102

4.2

Inhibition of caveolae-dependent endocytosis
when supplemented with BSA .......................................................... 104

4.3

Inhibition of clathrin-dependent endocytosis
when supplemented with FBS .......................................................... 106

4.4

Inhibition of clathrin-dependent endocytosis
when supplemented with BSA .......................................................... 108

4.5

Inhibition of macropinocytosis
when supplemented with FBS .......................................................... 110

4.6

Inhibition of macropinocytosis
when supplemented with BSA .......................................................... 112

xiv

LIST OF TABLES
Table

Page

AII-1 Hyclone Historical Data Sheet:
Characterization of Standard FBS .................................................... 136

xv

LIST OF IMAGES
Image

Page

AI-1

TEM characterization of 5nm citrate-capped spheres ............................ 125

AI-2

TEM characterization of 18nm citrate-capped spheres .......................... 126

AI-3

TEM characterization of 50nm citrate-capped spheres .......................... 127

AI-4

TEM characterization of 6nm PEG-capped spheres .............................. 128

AI-5

TEM characterization of 15nm PEG-capped spheres ............................ 129

AI-6

TEM characterization of 55nm PEG-capped spheres ............................ 130

AI-7

TEM characterization of 5nm PEI-capped spheres ................................ 131

AI-8

TEM characterization of 13nm PEI-capped spheres .............................. 132

AI-9

TEM characterization of 30nm citrate-capped spheres .......................... 133

AI-10 TEM characterization of 30nm citrate-capped spheres .......................... 134

xvi

CHAPTER 1
LITERATURE REVIEW:
THE ENVIRONMENTAL FATE AND EFFECTS OF
ENGINEERED NANOPARTICLES

1. INTRODUCTION
The novel properties that emerge as materials are taken to sizes of a few
billionths of a meter have driven the nanotechnology revolution and the
exponential growth of products and applications that utilize nanoparticles. These
materials present exciting opportunities for the development of new products,
enhancement of existing products, and the evolution of innovative procedures
from drug delivery to medical imaging. Nanoparticles are being examined for use
in various medical areas from imaging to the development of non-viral vectors for
gene therapy. At the same time, however, uncertainties regarding potential
deleterious effects of the interactions of nanoparticles with biological systems
have alarmed scientists and governmental agencies. These uncertainties have
the potential to polarize the public against possible benefits of nanotechnology as
the lack of adequate knowledge may lead to sensationalized press.
To elicit a direct biological response, nanoparticles must be bioavailable;
which usually means they must cross a membrane to reach an active site. Note,
however, that some nanoparticles may cause adverse effects through the
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release of ions or the generation of oxidizing equivalents without crossing a
membrane. In most organisms, the initial biological membrane encountered
during exposure is either lungs (gill or gill-like structures for aquatic organisms) or
gut tract. Nanoparticles have been shown to cross the blood-brain barrier, move
through embryonic zebrafish membranes, and enhance the transport of drugs
through membranes [1,2,3]. However, studies that quantitatively characterize the
influence of particle characteristics on such transport are currently lacking.
To accurately assess the impacts that nanoparticles may have on
biological systems, it is necessary to understand how these materials interact
with the environment. While organisms have been in contact with naturally
occurring nanoparticles since the beginning of time, there are two key concerns
surrounding the recent explosion in their manufacturing [4]. First, physical
differences

between

naturally

occurring

nanoparticles

and

engineered

nanoparticles must be characterized to determine if these differences might
result in adverse responses. Second, the interactions between engineered
nanoparticles and environmental and biological ligands must be characterized to
assess their influence on bioavailability.

The latter concern is particularly

important as we move from studying pristine nanoparticles to those that have
aged in the environment [4].
Most studies examining the impacts of nanoparticles involve exposures
with pristine, freshly prepared products. While these studies prove useful in
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understanding possible biological effects under rare conditions, they have done
little to further our understanding of what is occurring in the field. A greater
understanding of the aqueous solubility, rates of aggregation, reactivity, and
degradation of nanoparticles is warranted, and one may suspect that these
factors are inherently related to the physical properties of the particle itself. This
chapter reviews current research on the influence of particle characteristics on
biological uptake and environmental fate, while also identifying research needs in
this area.

2. NANOPARTICLE FATE IN THE ENVIRONMENT
To better understand how particles interact with biological systems in the
field, we must first comprehend the nature of nanoparticles in environmental
settings, as the influence that the environment has on particle characteristics will
need to be examined. It is inevitable that when engineered particles enter
ecological systems, their characteristics will be altered. What we do not know is
how this alteration will affect uptake and biotic responses. It is possible, and even
highly probable, that the alterations in particle characteristics, such as aging,
agglomeration, and aggregation, will cause different responses than what has
been suggested from previous laboratory studies.
Due to the unlimited combinations of nanoparticle characteristics, the
scientific community is concerned with the transport ability of these particles. It
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has been suggested that due to particle shapes and sizes, nanoparticles will be
intercepted, diffuse and settle from solution over time [5]. However, removal from
solution may not always occur, as an examination of transport and deposition of
fullerenes and oxide particles in porous media revealed that while fullerene and
oxide aggregates were efficiently removed from the system, hydroxylated
fullerenes remained highly mobile and were only removed at very low
percentages [6]. Studies on silica and anatase particles have concluded similar
results, as nearly half of the particles remained mobile and in solution [7]. Such
results contradict the common notion that all particles will sediment and slowly
become covered by organic matter and more sediment. However, it is generally
accepted that particles will aggregate and fall out of solution; for this reason there
is a need for more research with benthic species.
Apart from entering aquatic systems through run-off and deterioration,
nanoparticles used in medical applications or personal care products may find
their way into the environment through municipal and industrial wastewater
treatment facilities. The ionic strength in freshwaters, and especially in marine
environments, would increase the potential for engineered nanoparticles to
aggregate and sediment [8]. However, surface modifications can sometimes outcompete forces of Brownian motion size based interactions and remain in
solution. As a result, nanoparticle suspensions from wastewater discharges are
of great concern, for nanoparticles have been shown to associate with many
persistent contaminants of concern, including PAHs, dioxins, PCBs, PBDEs, and
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endocrine disruptors. Currently, it is unknown how nanoparticles may affect
contaminant bioavability and transport [5].

3. NANOPARTICLE UPTAKE IN VIVO
In vivo studies present an opportunity for some of the greatest
advancements in our understanding of nanoparticle interactions with biological
systems. Furthering our knowledge on the influence of particle size, shape, and
surface chemistry would benefit applications in human health systems, as well as
in settings of environmental health and safety. The current lack of knowledge in
these areas has greatly inhibited advancements in both the development of
biomedical applications as well the quantitative assessment of the risk of
nanoparticles to humans and ecosystems.
How nanoparticles interact with mammalian systems may depend on their
physical and chemical characteristics. Human exposures to asbestos particles
during mining operations and their widespread use led to a global pandemic of
lung diseases [9]. These diseases, including lung cancer and asbestosis, were
not only shown to be caused by the interactions of the asbestos fiber with lung
tissue, but were also shown to be related to fiber aspect ratio. Specifically, these
extreme detrimental effects were only present when initiated by thin, long
particles with diameters of 3µm and lengths longer than 20µm [9]. Recent
research has demonstrated that carbon nanotubes caused asbestos-like
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pathogenicity when introduced into the abdominal cavity of mice, and the
response, including inflammation and formation of granulomas, was size
dependent, varying as a function of carbon nanotube length [10].
Wittmaack [11] reviewed published dose-response data on lung
inflammation in rats and mice exposed to titanium dioxide or carbon
nanoparticles and concluded that particle number, joint length, and surface area
were useful metrics for data analysis. On the other hand, his results suggested
that particle size-based surface area was not a significant metric of analysis.
Other investigators have concluded that responses to nanoparticle exposure are
size

dependent.

Inhalation

studies

involving

rats

exposed

to

polytetrafluoroethylene and titanium dioxide nanoparticles have suggested that
induced lung inflammation was dependent on particle size [12]. When gold
nanoparticles were intratracheal instilled in rats, the response was also size
dependent, as smaller particles were removed from the lungs, and larger
particles remained sequestered in the lungs [13]. Furthermore, it has been
suggested that when exposed intravenously, small particles are easily eliminated
through renal excretion pathways and larger particles are localized in marrow,
the kidney, stomach, and associated with the phagocytic system and target
endothelial systems [14,15,16,17].
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While the impacts of particle size on uptake in mammals have been
examined with many particle types, the influence of shape is currently lacking in
the literature. However, when exposed to symmetrical and irregularly shaped
polymer lipid nanoparticles, rats were able to clear standard shapes easily from
the liver, while irregularly shaped particles remained localized in the spleen [18].
Such results suggest that particle shape is also an important characteristic that
should be considered when trying to develop structure activity relationships.
Daphnia magna are freshwater pelagic filter feeders that have been used
extensively in aquatic bioassays with nanoparticles. Due to their efficient filtering
of the water column, any particles in the water column enter their gut tract.
Furthermore, research from our laboratory suggests that effects on these
organisms may not be limited to biochemical changes, but may also be induced
by physical stressors surrounding the particle obstruction of gut tract function
[19].
Aquatic vertebrates, such as the Japanese medaka (Oryzias latipes) and
zebrafish (Danio rerio), are also subject to nanoparticle exposure. These
organisms are standard test species that have been comprehensively examined
in traditional solute toxicity tests, and have proven useful in investigating impacts
of nanoparticles. Target areas of concern for nanoparticle exposure to these
organisms include, but are not limited to, gills, gut, liver, and sometimes brains
[20].
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The shape of a nanoparticle may also determine how a particle interacts
with aquatic organisms. When embryonic zebrafish were exposed to spherical
nanoparticles versus dendritic rod shaped particles, there was no difference in
accumulation within the lumen with respect to particle shape [21]. However, while
the study could not conclusively link uptake to size differences, rod shaped
particles were found to be more toxic than their spherical counterparts, which
suggests that particle shape does lead to differences in levels of interaction for
embryonic fish.
Similarly, research from our laboratory has produced comparable results
with D. magna. Differences in toxicity were higher when exposed to carbon
nanotubes than gold nanospheres [19]. Furthermore, while particles of any shape
were not found to cross the lumen, retention times in the gut tract were slower for
oblong rods and faster for the symmetrical spheres.
How nanoparticles interact with organisms in aquatic systems may also
depend on the charge of the particle and the hydrophilicity of the particle surface.
When Japanese medaka were exposed to gold nanospheres of similar size and
shape with ligand attachments on their surfaces, uptake and bioaccumulation
was greatest in fish intestines and gills, and lower in dorsal fins, brains, hearts,
gonads, and livers [22]. More importantly, however, was the charge dependent
uptake in these regions, as uptake was highest among cationic hydrophobic
particles. Furthermore, cationic hydrophobic particles were widely distributed in
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many organs and caused high mortality within 24 hr. All hydrophilic species, on
the other hand, were able to be excreted and are suggested to pose little impact
on environmental health and safety.

4. NANOPARTICLE UPTAKE IN VITRO
Nanoparticles must be bioavailable in order to elicit a biological response,
and to reach an active site they must usually cross a membrane. As a result, cell
culture studies have proven to be beneficial and are generally one of the first
tests conducted upon the synthesis of a new particle type. A major drawback,
however, to current literature involving interactions between cells and
nanoparticles is the lack of information provided, poor techniques, and lack of
transparency in methods of analysis. A standardization of methods and data
analysis

involving

cells

and

nanoparticles

would

facilitate

the

future

understanding of the underlying mechanisms behind their transport across cell
membranes.
Research has demonstrated that gold nanoparticles approximately 1nm in
diameter can penetrate membranes of HeLa cervical cancer cells, as well as the
nuclear membrane and even attach to DNA [23]. Larger gold nanoparticles have
also been shown to cross membranes. These include 14 nm citrate-coated gold
nanoparticles taken up by human dermal fibroblasts and 18nm particles taken up
by a human leukemia cell line, K562 [24, 25]. Cytotoxicity, as a function of
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uptake, is also dependent upon particle size with exposure to smaller particles
resulted in more toxicity when tested in four different cell lines [26]. However,
there are conflicting results in the literature as to the influence of size on
nanoparticle uptake. Thurn et al. [27] suggested that exposure to smaller
particles resulted in the greatest uptake while Chithrani et al. [28] reported that
larger particles of sizes averaging 50nm were taken up to a greater extent than
smaller particles.
The shape of a nanoparticle also determines how it may enter a cell.
Simply put, particles of oblong shape may not effectively reach a receptor site on
the membrane, require more energy for processes of endocytosis, or would be
less favorable to engulfment than more symmetrical shapes. In a study
investigating nanorods and nanospheres of varying sizes, Chithrani et al. [28]
concluded that levels of interaction were dependent upon shape, as the uptake of
rod-shaped nanoparticles was lower than their spherical counterparts.

Aside

from this study, other studies examining the influence of particle shape on uptake
in biological systems are severely lacking [27].
Just as size has an influential role in interactions between nanoparticles
and cells, so does the surface chemistry including particle charge. This line of
research is extremely important for areas of research involving drug delivery and
imaging as there are times when a high level of interaction between cells and
particles is desirable, and other times when no interaction is preferred [29].
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Chung et al. [30] reported that the uptake of mesoporous silica particles was
greatest in human mesenchymal stem cells when the particle surfaces had a
positive charge. Positively charged particles are believed to have higher uptake
rates in cells than negatively charged particles due to the overall negative net
charge of cell membranes [27]. Neutrally charged particles, which resist protein
sorption, result in the lowest levels of uptake [29].
Cell culture medium is commonly supplemented with serum proteins, as
they are vital components necessary for cell growth and survival. As
nanoparticles are introduced into the medium, the supplemented proteins readily
sorb to particle surfaces due to hydrophobic and electrostatic interactions [31,32].
These interactions occur rapidly, require little external energy (e.g. mixing) and
particles are completely coated with serum proteins within seconds to minutes
[33]. Coincidentally, without this interaction nanoparticles would aggregate due to
the ionic strength of the culture media [28,34]. Cell uptake of nanoparticles is
dependent upon adsorbed proteins on their surface; these proteins interact nonspecifically with membrane surfaces resulting in the endocytosis of the particleprotein complex [28]. Fetal bovine serum (FBS), a widely used media
supplement, contains an array of different proteins, each of which has the
potential to interact differently with a nanoparticle and the interaction may be
driven by protein and particle specific characteristics. [33,35]. Since different
proteins are known to enter cells through different mechanisms, understanding
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the complex protein-particle relationship will help to further understand the
processes by which nanoparticles enter cells [28].
Nanoparticles enter cells through three principal routes of endocytosis:
clathrin-dependent, caveolae-dependent, and macropinocytosis [36]. Clathrindependent endocytosis is the mechanism by which surface proteins are taken up
at specialized sites in the cell membrane where clathrin is recruited to form pits
that are cleaved by dynamin to localize cargo into endosomes [37]. Caveolaedependent endocytosis occurs similarly to clathrin-dependent in that surface
proteins are collected in invaginations cleaved by dynamin and localized into
endosomes; however this mechanism relies on the recruitment of caveolin and
presence of cholesterol for internalization [38]. Macropinocytosis is a less
understood mechanism of endocytosis in which membrane structures formed by
actin filaments, such as lamellipodia, ruffles, and blebs, engulf macromolecules
and particles into intracellular macropinosomes.
Previous studies have successfully described the utilization of different
endocytotic pathways by nanoparticles through the use of pharmacological
inhibitors [39,40,41]. However, all nanoparticles do not follow the same route of
uptake. Instead, the mode of particle uptake is dependent upon many factors
including, but not limited to, cell type, cell function, available proteins for
conjugation, particle type, and particle characteristics. Further research is
warranted to decipher how each of these interactions alters the uptake of
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nanoparticles to facilitate the advancement of biomedical applications as well as
risk assessment endeavors.

5. RESEARCH NEEDS AND CONCLUSIONS
Over the past decade, much effort has been made to investigate the
effects of nanoparticles on a parallel level with their increased production.
However, with current estimates suggesting less than 10% of all funding in nanorelated disciplines is in areas of environmental health and safety, our
understanding of their interactions with the environment around us is a mere
fraction of the knowledge we now have concerning their possible benefits to
society. To decrease the uncertainties currently surrounding the exposure,
effects, and risk characterization of nanoparticles, more research must be
conducted.
A major drawback to this advancement is not in our inability to detect
nanoparticles, but in our inability to distinguish them from bulk materials [42].
With future advancements in analytical techniques and instrumentation, greater
steps towards risk characterization will be made. Until then, however, it is
necessary to use the tools and methods that are currently available to produce
transparent, reproducible, high quality results. As evident in this review, particles
characteristics are vital parameters to understanding particle interactions with
environmental systems. As a result, it is imperative for future studies to account
for these parameters in the analysis of their results.
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While there is information concerning the effects of the physical
characteristics of nanoparticles, most have done so independently of each other.
Research investigating the collective influence that particle size, shape, and
surface chemistry have on environmental interactions for a given core particle is
both crucial and necessary to advance our understanding of the negative effects
of particles, as well as their benefits. A complete characterization of uptake is
necessary to accurately predict particle uptake. Furthermore, research
investigating the processes by which particles interact with environmental media
and processes by which they are taken up is also warranted. As a result, the
goal of my dissertation is to characterize the uptake of gold nanoparticles by the
mammalian cell line A549 through determining the roles of particle characteristics
and culture medium components, and by describing potential modes by which
particles are endocytosed. This information will facilitate future advancement in
the field of nanotoxicology, while also decreasing the uncertainties currently
surrounding the exposure, effects, and risk characterization of nanoparticles [4].
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CHAPTER 2
THE INFLUENCE OF PARTICLE SIZE AND
SURFACE CHEMISTRY ON THE CELLULAR
UPTAKE OF GOLD NANOPARTICLES
ABSTRACT: This study assessed the influence of the physical and chemical
characteristics of gold nanospheres on their uptake by the mammalian cell line
A549. A semi-factorial design was followed, examining three different particle
sizes (roughly 5nm, 15nm and 50nm) modified by three different surface charges
(anionic, cationic, and nonionic). The influence of particle concentration on
cellular uptake was analyzed for 5nm and 50nm citrate-capped spheres over 24
h. Particle uptake increased as exposure concentration increased. The influence
of particle size and surface charge on uptake was analyzed for each particle type
over 2 h. With the exception of 50nm nonionic particles, uptake was charge
dependent, as cationic particles were taken up to a greater extent than anionic
particles, which were taken up more than nonionic particles. The uptake of gold
nanoparticles was also dependent on particle size but this relationship may be a
function of particle surface charge because particle uptake was greatest for
larger negatively charged particles, and for smaller positively charged particles.
Results may help to predict particle interactions with biological systems and
facilitate future endeavors of quantifying the risk of particle release into the
environment, as uptake cell is dependent on an array of particle characteristics.
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1. INTRODUCTION
The recent growth of products and applications that contain, or utilize,
nanoparticles has occurred in the absence of detailed knowledge of the
interactions of these particles with environmental processes. According to the
Woodrow Wilson Center’s Project on Emerging Nanotechnologies, there are over
1,000 consumer products on the market that contain or utilize nanoparticles. This
number is expected to grow exponentially, as the potential use of these materials
is unlimited. Currently, there is a need for quantitative research that provides a
foundation upon which to predict biological interactions with nanoparticles. This
information would facilitate both product development and future endeavors
towards accurate assessments to the risk that nanoparticles may pose on the
environment.
Due to their ability to cross cell membranes, gold nanoparticles have been
proposed for detection of viruses, bacteria, and toxins; medical imaging; drug
delivery; and cancer therapy applications [1]. Gold nanoparticles also serve as
ideal model particles in research endeavors on particle uptake due to their
stability and relatively low toxicity [2]. Gold particles are also easily synthesized in
a variety of shapes, including, but not limited to, spheres, rods, cones, diamonds,
and sheets. Also, the relative sizes of the shapes are able to be controlled,
resulting

in

monodisperse

solutions

[3].

Furthermore,

it

is

relatively

straightforward to modify the surfaces of these particles with an array of coatings
that result in differences in charge and polarity that could influence their
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interactions with biological membranes. However, studies that quantitatively
characterize the influence of particle size and surface chemistry are currently
lacking.
Nanoparticles must be bioavailable to result in a biological response, and
to reach an active site they must usually cross a membrane. Many biomedical
applications of nanoparticles rely on their ability to cross membranes; therefore,
the ability to predict particle movement based on physical characteristics would
enhance

both

product

development

and

product

application.

Similarly,

environmental regulators are also interested in the potential for particles to cross
membranes since these particles may pose the greatest risk.
The goal of this study was to investigate the influence of particle
characteristics on the uptake of gold nanoparticles in mammalian cells. This
study tests the hypothesis that particle uptake is a function of a particle’s
chemical and physical characteristics. Potentially, each change elicits a new
material that has the potential to interact differently with biological systems. This
study is the first to collectively investigate the role of varying particle
characteristics for a given core chemistry under the same conditions within the
same cell line, which is critical to accurately model particle uptake. With the
recent explosion of commercial products utilizing nanotechnology, it is imperative
that predictive relationships be developed between particle characteristics and
particle fate and effects to facilitate quantitative evaluation of risk.
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2. MATERIALS AND METHODS
2.1 Particle Synthesis
Citrate-capped gold nanospheres, 5nm, 18nm, and 50nm, were obtained
from the laboratory of Professor Catherine Murphy, University of Illinois at
Urbana–Champaign.

Particles

were

synthesized

by

methods

previously

described [4]. Briefly, 5nm citrate-capped particles were prepared by adding
0.5ml 0.01M HAuCl4 and 0.5ml 0.01M citrate solution to 19ml ultrapure water.
The mixture was stirred as 0.1M NaBH4 was added, and the solution was allowed
to mix for 2-3 hours. The 18nm particles were synthesized by adding 2.5ml
0.01M HAuCl4 to 100ml ultrapure water while stirring, brought to a boil, and a 1%
citrate solution was added to the mixture. The solution was stirred and boiled for
15-20 minutes until the solution was a deep red. The 50nm particles were
synthesized by combining 2.25ml 18nm particles, 2.44ml 0.01M HAuCl4, and
250ml ultrapure water, brought to a boil, and 4ml of 0.01M ascorbic acid solution
was added. The solution was stirred and boiled for 1 hour until it turned purple
with a brown tint.
Polyethylene glycol-capped nanoparticles (PEG) of 6, 15 and 55nm were
obtained from the laboratory of Professor Christopher Kitchens, Clemson
University. HAuCl4 of 99.995% purity was purchased from Alfa Aesar; sodium
borohydride was purchased from EMD Chemicals; both were used as received.
Polyethylene glycol-thiol, PEG-SH, 1000 MW, was purchased from Laysan Bio,
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Inc. Particles were synthesized using a modified procedure described previously
[4,5]. The 6nm particles were synthesized using a modification of the citrate
synthesis in which a 50 mL solution of 0.25mM HAuCl4 was reduced with 0.5 mL
of iced 0.1M NaBH4 in the presence of PEG-SH (0.25mM) instead of citrate. The
15 nm particles were synthesized using a citrate seeding procedure in which 1mL
of 0.1M aqueous citrate was added to 49mL of DI H2O and brought to a boil while
stirring. Once a rolling boil was reached, 0.5 mL of 0.05M aqueous HAuCl4 was
added and the solution was boiled for 10 minutes until the solution turned a bright
red color. The solution was then allowed to cool and the citrate was ligand
exchanged with PEG-SH. The 55 nm particles were synthesized by bringing a 50
mL solution of 0.25 mM HAuCl4 to a rolling boil, then adding 0.25 mL of 20 nm
gold citrate particles and 0.05 mL of 0.05mM citrate. The solution boiled for 15
minutes and then stirred for an additional 10 minutes without heat. The citrate
was then ligand exchanged with PEG-SH.
Polyethyleneimine-capped nanoparticles (PEI) of 5 and 13nm were
obtained from the laboratory of Professor Christopher Kitchens, Clemson
University. Particles were synthesized using a modified procedure described
previously [6]. Briefly, 5nm particles were synthesized by adding 2wt% PEI and
1mM HCl to 20ml ultrapure water while stirring, followed by the addition of 0.05M
NaBH4. The solution was stirred for 15 minutes. The 13nm particles were
synthesized by adding 2wt% PEI and 1mM HCl to 20ml ultrapure water. Particles
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were gradually synthesized over the several days through the slow process of
PEI reduction.

2.2 Particle Characterization
Particles were characterized in ultra-pure water for size and morphology
using transmission electron microscopy (TEM) techniques (Clemson University
Electron Microscopy Laboratory).

Relative particle sizes were obtained by

dynamic light scattering (DLS), and a measure of the electrokinetic potential
(zeta potential) for each particle type was obtained. DLS and zeta measurements
for citrate and PEG particles were analyzed using a Zetasizer (Malvern), while
PEI particles were analyzed with a 90Plus Particle Size Analyzer (Brookhaven).
Particles were analyzed after digestion in aqua regia (nitric acid:hydrochloric
acid, 1:3 respectively), and dilution to a 5% acid solution. Gold mass was
analyzed via inductively coupled plasma-mass spectrometry (ICP-MS) (Thermo
Scientific XSeries 2).

2.3 Cell Culture
A549 adenocarcinomic human alveolar basal epithelial cells (ATCC,
Rockville MD) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with 4.5 g/l glucose, 584mg/l L-glutamine, and 110mg/l sodium pyruvate
(Mediatech, Inc., Manassas, VA). DMEM was supplemented with 10% fetal
bovine serum (HyClone, Logan, UT), 1% penicillin/streptomycin (HyClone), and
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2% non-essential amino acids (Sigma-Aldrich, St. Louis, MO) to form complete
growth medium. Cells were cultured in 75cm2 sterile, polystyrene, tissue culturetreated, vented flasks under clean conditions (Corning, Corning, NY), and
incubated under 5% CO2 at 37°C as described previously [7, 8].
For subculturing, cells in flasks were rinsed with 1X PBS (Fisher Scientific,
Waltham, MA), and incubated in a 0.25% trypsin (Sigma-Aldrich) solution for 515 minutes, or until cells detached from the flask surface. Complete growth
media was then added to inhibit trypsin activity, and cells were aspirated and
transferred to sterile centrifuge tubes (Corning). Cells were centrifuged at 3,000
rpm (1,400 g) for three minutes, after which the supernatant was removed and
discarded. Cells were then resuspended in complete growth medium, diluted,
and transferred to sterile flasks. When not in use, cells were cryopreserved at -80
°C in complete growth media supplemented with 5% dimethyl sulfoxide (DMSO)
(Fisher Scientific).

2.4 Cell Exposures
Cells were removed from flasks using a 0.25% trypsin solution, and plated
in sterile, polystyrene, tissue culture-treated 12-well plates (Costar, Corning, NY)
at 100,000 cells per well. Cells were plated in complete growth medium and
allowed 24 h for attachment to the plate surface [9]. After 24 h, the complete
growth

media

was

aspirated,

and

exposure

nanoparticles was carefully added to each well.
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medium

containing

gold

2.4.1 Influence of Particle Concentration
Cells were exposed to increasing gold concentration of 5nm and 50nm
negatively charged citrate-capped gold nanospheres for 24 h (n=3). Specifically,
cells were exposed to 5nm particles at concentrations of 0.04 mg/l, 0.08mg/l,
0.16mg/l, and 0.32 mg/l, and 50nm particles at concentrations of 0.8mg/l,
1.6mg/l, 3.2mg/l, and 6.4mg/l.

2.4.2 Influence of Particle Characteristics
Cells were exposed to eight forms of gold nanospheres of differing size
and surface charge (n=3). These particle types included 5nm negatively charged
citrate-capped spheres, 18nm negatively charged citrate-capped spheres, 50nm
negatively charged citrate-capped spheres, 6nm neutrally charged PEG-capped
spheres, 15nm neutrally charged PEG-capped spheres, 55nm neutrally charged
EPG-capped spheres, 5nm positively charged PEI-capped spheres, and 13nm
positively charged PEI-capped spheres. Cells were exposed to each particle type
at a concentration of 1mg/l for 0.5, 1.0, 1.5, and 2.0 h. The majority of previous
examining the uptake of nanoparticles by cells have focused on 24 h uptake;
however, many cells, including A549, double within 24 h. In an effort to limit the
variability and impact of cell growth on my results, exposures were shortened to
2 h.
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2.5 Analytical Procedure
At the end of each time-point, exposure medium was removed and cells
were carefully rinsed with 1X PBS to remove residual particles. Gold
nanospheres were then digested within each well following the addition of 1ml
30% aqua regia, and plates were incubated at 37°C under 5% CO2 for 30
minutes. Samples were removed from each well and diluted to a 5% acid
solution.

Gold uptake was analyzed via inductively coupled plasma-mass

spectrometry (ICP-MS) (Thermo Scientific XSeries 2).

2.6 Data Analysis
Data presented are in a mass-basis format (Au ng/105 Cells) and
represent the average and standard deviation of triplicate samples. All statistical
analysis was performed using SAS and JMP Pro 10 (SAS Institute, Cary, NC,
USA). Statistically significant differences were determined by a one way analysis
of variance (ANOVA) in conjunction with Tukey-Kramer’s test for post hoc
analysis or a t-test. A p value less than 0.05 was considered statistically
significant.
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3. RESULTS
3.1 Particle Characterization
Using TEM, citrate-capped gold nanoparticles were found to be spherical
in shape with diameters of 5nm (4.97±1.48), 18nm (18.06±3.77), and 50nm
(49.87±12.26) (Appendix I: Image AI-1, Image AI-2, and Image AI-3,
respectively). DLS estimated that 5nm citrate particles had a diameter of 11nm
(10.69±0.27), 18nm citrate particles had a diameter of 20nm (20.13±0.49), and
50nm citrate particles had a diameter of 60nm (59.89±0.11).
TEM analysis revealed that PEG-capped gold nanoparticles were
spherical in shape with diameters of 6nm (6.16±1.94), 15nm (15.10±2.01), and
55nm (54.84±22.31) (Appendix I: Image AI-4, Image AI-5, and Image AI-6,
respectively). DLS estimated that 6nm PEG particles had a diameter of 41nm
(41.39±0.55), 15nm PEG particles had a diameter of 22nm (22.15±0.39), and
55nm PEG particles had a diameter of 60nm (60.86±0.41).
TEM analysis revealed that PEI-capped gold particles were spherical in
shape with diameters of 5nm (4.77±2.14), and 13nm (13.38±4.49) (Appendix I:
Image AI-7 and Image AI-8, respectively). DLS estimated that 5nm PEI particles
were 18nm (17.52±0.80) in diameter and that 13nm PEI particles were 25nm
(24.79±0.65) in diameter. While a degree of polydispersity is inevitable in particle
synthesis, particles were monodisperse with respect to average particle sizes
described.
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Zeta potential measurements for citrate-capped spheres were -30mV for
5nm particles, -45mV for 18nm particles, and -40mV for 50nm gold nanospheres.
Zeta potential measurements for PEG-capped spheres were -12mV for 6nm
particles, -18mV for 15nm particles, and -8mV for 55nm particles. Zeta potential
measurements for PEI-capped particles were 34mV for 5nm particles and 32 mV
for 13nm particles. The measurements suggest that particles used in this study
were appropriately charged and stable in suspension.

3.2 Influence of Particle Concentration
Cells were exposed to increasing concentration of 5nm and 50nm
negatively charged citrate-capped gold nanospheres for 24 h. Uptake of 5nm
citrate-capped spheres was concentration dependent and was positively related
to exposure concentration (Figure 2.1). After 24 h, gold uptake in 105 cells was
0.17±0.03ng when exposed to 0.04mg/l, 0.30±0.05ng when exposed to 0.08mg/l,
0.63±0.07ng when exposed to 0.16mg/l, and 0.91±0.08ng when exposed to
0.32mg/l 5nm citrate-capped gold nanospheres.
Uptake of 50nm citrate-capped spheres was also concentration dependent
and was positively related to exposure concentration (Figure 2.2). After 24 h,
gold uptake in 105 cells was 2.56±0.33ng when exposed to 0.8mg/l,
52.44±0.79ng when exposed to 1.6mg/l, 179.82±6.80 when exposed to 3.2mg/l,
and 457.28±24.56ng when exposed to 6.4mg/l 5nm citrate-capped gold
nanospheres.
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Figure 2.1: The uptake of 5nm citrate-capped spheres at increasing
concentrations over 24 h (mean ± standard deviation, n=3). Uptake was dosedependent, and increased as the concentration of particles increased.
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Figure 2.2: The uptake of 50nm citrate-capped spheres at increasing
concentrations over 24 h (mean ± standard deviation, n=3). Uptake was dosedependent, and increased as the concentration of particles increased.
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3.3 Influence of Particle Characteristics
Cells were exposed to eight forms of gold nanospheres of differing size
and surface charge. Cells were exposed to each particle type for a period of 0.5,
1.0, 1.5, and 2.0 h, and uptake was positively related to exposure time, with the
exception of 5nm PEG and 50nm PEG particles for which uptake was extremely
low and variable.
Cells were first exposed to 5nm, 18nm, and 50nm citrate-capped gold
nanospheres (Figure 2.3). Gold uptake of 5nm particles in 105 cells was
2.42±1.20ng after 0.5 h, 8.31±1.27ng after 1.0 h, 12.12±2.63ng after 1.5 h, and
12.96±2.90ng after 2.0 h of exposure. Gold uptake of 18nm particles in 105 cells
was 5.31±0.71ng after 0.5 h, 11.79±1.77ng after 1.0 h, 17.98±4.32ng after 1.5 h,
and 23.70±0.47ng after 2.0 h of exposure. Gold uptake of 50nm particles in 105
cells was 1.15±0.18ng after 0.5 h, 10.06±3.73ng after 1.0 h, 14.98±0.97ng after
1.5 h, and 25.66±1.90ng after 2.0 h of exposure.
Cells were exposed to 6nm, 15nm, and 55nm PEG-capped gold
nanospheres (Figure 2.4). Gold uptake of 6nm particles in 105 cells was below
the limit of detection (LOD, 0.1ng/105 cells) after 0.5 h, 0.71±0.62ng after 1.0 h,
0.36±0.35ng after 1.5 h, and 0.78±0.10ng after 2.0 h of exposure. Uptake of
15nm particles in 105 cells was below the LOD after 0.5 h, 1.40±0.73ng after 1.0
h, 0.66±0.10ng after 1.5 h, and 0.27±0.33ng after 2.0 h of exposure. Gold uptake
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Figure 2.3: The uptake of citrate-capped spheres over 2 h (mean ± standard
deviation, n=3), when exposed to 1mg/l gold concentration.
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Figure 2.4: The uptake of PEG-capped spheres over 2 h (mean ± standard
deviation, n=3), when exposed to 1mg/l gold concentration.
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of 55nm particles in 105 cells was 7.18±1.10ng after 0.5 h, 54.11±2.00ng after 1.0
h, 110.88±3.50ng after 1.5 h, and 173.02±2.29ng after 2.0 h of exposure.
Cells were exposed to 5nm and 13nm PEI-capped gold nanospheres
(Figure 2.5). Gold uptake of 5nm particles in 105 cells was 18.81+1.68ng after 0.5
h, 33.13±0.38ng after 1.0 h, 38.50±1.68ng after 1.5 h, and 45.84±1.26ng after
2.0 h of exposure. Gold uptake of 13nm particles in 105 cells was 16.32±0.89ng
after 0.5 h, 28.40±0.50ng after 1.0 h, 36.62±1.09ng after 1.5 h, and
40.75±1.77ng after 2.0 h of exposure.

3.4 Influence of Particle Size
To investigate the influence of particle size on the uptake of gold
nanoparticles, comparisons among levels of uptake after 2 h were conducted
among particles of the same surface chemistry. Average particle uptake of
citrate-capped

gold nanospheres

was

12.96±2.90ng for 5nm

particles,

23.70±0.47ng for 18nm particles, and 25.66±1.90ng for 50nm particles when 105
cells were exposed (Figure 2.6). An analysis of variance (ANOVA) in conjunction
with a Tukey-Kramer HSD post hoc test was conducted to compare means of
each particle type. The uptake of 5nm particles was significantly lower than the
uptake of 18nm particles (p=0.0015), as well as significantly lower than the
uptake of 50nm particles (p=0.0006). There was no significant difference
between the uptake of 18nm and 50nm citrate-capped gold nanospheres
(p=0.5014).
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Figure 2.5: The uptake of PEI-capped spheres over 2 h (mean ± standard
deviation, n=3), when exposed to 1mg/l gold concentration.

39

Figure 2.6: Comparison of particle size dependence on citrate-capped particle
uptake after 2 h exposure to 1mg/l gold (mean ± standard deviation, n=3).
Values with the same letter are not statistically different from each other.
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The average particle uptake of PEG-capped gold nanospheres after 2 h
exposure was 0.78±0.10ng for 6nm particles, 0.27±0.33ng for 15nm particles,
and 173.02±2.29ng for 55nm particles when 105 cells were exposed (Figure 2.7).
An analysis of variance (ANOVA) in conjunction with a Tukey-Kramer HSD post
hoc test was conducted to compare means of each particle type. There was no
significant difference between the uptake of 6nm and 15nm particles (p=0.8907).
The uptake of 55nm particles was significantly greater than the uptake of 6nm
particles (p<0.0001), as well as significantly greater than the uptake of 15nm
particles (p<0.0001).
The average particle uptake of PEI-capped gold nanospheres after 2 h
exposure was 45.84±1.26ng for 5nm particles and 40.75±1.77ng for 13nm
particles when 105 cells were exposed (Figure 2.8). A t-test was conducted to
compare means of the two particle types. The uptake of 5nm particles was
significantly greater than the uptake of 13nm particles (p=0.0190).

3.5 Influence of Particle Surface Charge
To investigate the influence of surface chemistry differences on the uptake
of gold nanoparticles, comparisons between levels of uptake after 2 h were
conducted among particles of similar size and different surface charges. Average
particle uptake for 5nm citrate-capped spheres was 12.96±2.90ng, 6nm PEGcapped spheres was 0.78±0.10ng, and 5nm PEI-capped spheres was
45.84±1.26ng when 105 cells were exposed (Figure 2.9). An analysis of variance
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Figure 2.7: Comparison of particle size dependence on PEG-capped particle
uptake after 2 h exposure to 1mg/l gold (mean ± standard deviation, n=3). Values
with the same letter are not statistically different from each other.
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Figure 2.8: Comparison of particle size dependence on PEI-capped particle
uptake after 2 h exposure to 1mg/l gold (mean ± standard deviation, n=3). Values
with the same letter are not statistically different from each other.
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Figure 2.9: Comparison of particle charge dependence on 5-6nm particle uptake
after 2 h exposure to 1mg/l gold (mean ± standard deviation, n=3). Values with
the same letter are not statistically different from each other.
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(ANOVA) in conjunction with a Tukey-Kramer HSD post hoc test was conducted
to compare means of each particle type. For the smallest particles, the uptake of
cationic PEI-capped particles was significantly greater than the uptake of anionic
citrate-capped particles (p<0.0001), as well as significantly greater than the
uptake of nonionic PEG-capped particles (p<0.0001). Furthermore, the uptake of
nonionic PEG-capped particles was significantly lower than the uptake of anionic
citrate-capped particles (p=0.0004).
Average

particle

uptake

for

18nm

citrate-capped

spheres

was

23.70±0.47ng, 15nm PEG-capped spheres was 0.27±0.33ng, and 13nm PEIcapped spheres was 40.75±1.77ng when 105 cells were exposed for 2 h (Figure
2.10). An analysis of variance (ANOVA) in conjunction with a Tukey-Kramer HSD
post hoc test was conducted to compare means of each particle type. For the 1418nm particles, the uptake of cationic PEI-capped particles was significantly
greater than the uptake of anionic citrate-capped particles (p<0.0001), as well as
significantly greater than the uptake of nonionic PEG-capped particles
(p<0.0001). Once again, the uptake of nonionic PEG-capped particles was
significantly lower than the uptake of anionic citrate-capped particles (p<0.0001).
The average particle uptake for 50nm citrate-capped spheres was
25.66±1.90ng and 55nm PEG-capped spheres was 173.02±2.29ng when 105
cells were exposed for 2 h (Figure 2.11). A t-test was conducted to compare
means of the two particle types, and the uptake of nonionic PEG-capped

45

Figure 2.10: Comparison of particle charge dependence on 14-18nm particle
uptake after 2 h exposure to 1mg/l gold (mean ± standard deviation, n=3). Values
with the same letter are not statistically different from each other.
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Figure 2.11: Comparison of particle charge dependence on 50-55nm particle
uptake after 2 h exposure to 1mg/l gold (mean ± standard deviation, n=3). Values
with the same letter are not statistically different from each other.
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particles was significantly greater than the uptake of 50nm anionic citrate-capped
particles (p<0.0001).

3.6 Size and Surface Effects
To examine the combined roles that particle size and surface charge, an
analysis of variance (ANOVA) in conjunction with a Tukey-Kramer HSD post hoc
test was conducted to compare means of each particle type that were tested
(Figure 2.12). Overall, uptake was greatest among 55nm PEG-capped particles
(173.02±2.29ng, p<0.0001). With the exception of 55nm PEG-capped particles,
surface charge was the determining factor in uptake as cationic particles were
taken up to a greater extent than anionic particles, which were taken up to a
greater extent than nonionic particles.
Within the set of cationic particles, uptake of 5nm PEI-capped particles
(45.84±1.26ng) was significantly greater than that of 13nm PEI-capped particles
(p=0.0303). There was no significant difference among anionic 50nm citratecapped

particles

(25.66±1.90ng)

and

18nm

citrate

capped

particles

(23.70±0.47ng) (p=0.8280); however, both were taken up significantly more than
the uptake of 5nm citrate-capped particles (12.96±2.90ng) (p<0.0001). Finally,
uptake was lowest among nonionic 6nm PEG-capped particles (0.78±0.10ng)
and 15nm PEG-capped particles (0.27±0.33ng), but there was no significant
difference between the two particle types (p=0.9999).

48

Figure 2.12: Collective comparison of particle charge and size dependence on
uptake after 2 h exposure of 1mg/l gold (mean ± standard deviation, n=3). Values
with the same letter are not statistically different from each other.
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4. DISCUSSION
In my study, the uptake of both 5nm and 50nm citrate-capped gold
nanospheres exhibited a dose dependent relationship, as uptake increased with
an increase in exposure concentration. Chithrani et al. [10] have also examined
the dependence of particle concentration on the uptake of citrate-capped
nanospheres by HeLa cells. Their analysis revealed that the uptake of 14nm,
50nm and 74nm particles was also dose-dependent. However, in their study,
uptake plateaued. Furthermore, they estimated that HeLa cells were only able to
take up 3000 14nm particles, 6160 50nm particles, and 2988 74nm particles.
Chithrani et al. [10] also conducted studies in which they examined the
dependence of particle size and shape on the uptake of citrate-capped
nanospheres by HeLa cells. In their study, they compared the uptake of 14nm,
30nm, 50nm, 74nm, and 100nm particles. Uptake increased as particle size
increased from 14nm-50nm. However, uptake declined as particle size increased
over 50nm, such that the uptake of 74nm particles was similar to that of 30nm
particles, and the uptake of 100nm particles was lower than the uptake of 14nm
particles. While we I did not see a significant difference in the uptake of 50nm
citrate particles in comparison to 18nm citrate particles, my results are similar in
that the uptake of 50nm particles was greater than that of smaller, 5nm particles.
PEG coated particles are designed to resist protein adsorption, which
could greatly alter their levels of uptake as many studies suggest protein sorption
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is a major facilitator of particle uptake [10,11]. Nativo et al. [12] found that gold
nanoparticles coated in PEG are not taken up by HeLa cells. My results are
similar to their study in that minimal uptake by 6nm and 15nm particles was
observed. However, in my study uptake was greatest, for all particle types, with
50nm PEG-coated gold nanospheres. This response could be due to differences
in the spatial configurational freedom of the PEG chains on the surface of the
particle types, as alterations in the architectural structure of the chains can lead
to protein interaction, thus enhancing uptake [11, 13, 14].
With exception of 50nm PEG-coated gold nanospheres, I observed the
greatest uptake in positively charged particles, followed by negatively charged
particles, and finally, smaller particles with a neutral charge. A thorough review
by Thurn et al. [15] examined the uptake of particles of different core chemistries,
including titanium dioxide, quantum dots and gold, and varying surface charges.
They describe that cells preferentially took up positively charged particles in
comparison to negatively charged particles. A review by Verma and Stellacci [11]
arrived at the same conclusion that the uptake was greatest in cells exposed to
positively charged particles. Thurn et al. [15] attributed this phenomenon to the
negative charge of the cell membrane.
Results from this study suggest that the charge of the particles surface is
the most important factor contributing to enhanced gold nanoparticle uptake, as
positively charged particles were taken up greater than negatively charged
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particles. Investigations into the effect of surface charge on the uptake of
mesoporous silica nanoparticles by mesenchymal stem cells suggest this as well;
as uptake was correlated to positively charged particles [16]. These results have
also been observed in vivo with gold nanoparticles, as the bioaccumulation of
particles in medaka fish intestines and gills was highest among those with
positively charged surfaces [17]. This further validates the need for accurate
modeling of particle interactions with membrane surfaces, as in vitro testing may
prove capable of predicting in vivo responses to nanoparticle exposures.
However, it is quite possible that these results are not simply due to the
negative charge of the cell membrane [15]. Instead, cells and tissues likely
recognize the proteins that readily and rapidly sorb to particle surfaces due to
hydrophobic and electrostatic interactions [18,19,20]. Hence, it is critical to
further investigate the particle-protein interactions involved and the formation of
protein coronas, as the surface charge of the particle determines the proteins
involved in corona formation; which may ultimately regulate biological responses
[21].

5. CONCLUSIONS
Nanoparticle uptake was dependent upon both concentration of exposure,
as well as length of exposure. The uptake of gold nanoparticles was also
dependent on particle size but this relationship is a function of particle surface
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charge; as particle uptake was greatest in larger negatively charged particles and
in smaller positively charged particles. With exception to 55nm PEG particles,
uptake was ultimately dependent upon particle surface charge; as cells
preferentially took up positively charged particles over negatively charged
particles, followed by neutrally charged particles. However, further investigation
is needed to accurately predict the roles of particle characteristics to facilitate
future assessments of risk that these particles may have on biological systems.
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CHAPTER 3
NOVEL APPROACHES TO ELUCIDATE SERUM
COMPONENTS INVOLVED IN THE CELLULAR
UPTAKE OF NANOPARTICLES
ABSTRACT: This study assessed the influence of the serum components of
cell growth media on the uptake of 30nm gold nanospheres by the mammalian
cell line A549. Cells were exposed to particles with exposure media
supplemented with differing concentrations of fetal bovine serum (FBS) and
bovine serum albumin (BSA). The uptake of particles exposed in FBS was
inversely related to protein exposure concentration, which was not observed with
particles in media supplemented with BSA, suggesting that certain components
of FBS deter particle uptake. Cells were also exposed in media supplemented
with dialyzed FBS, charcoal/dextran treated FBS, and FBS that contained lower
concentrations of immunoglobulin G (IgG) than found in standard FBS. Particle
uptake increased significantly following charcoal/dextran treatment suggesting
that growth factors and steroids may inhibit particle uptake. Cells were exposed
in media supplemented with BSA in addition to apolipoproteins, fetuin,
hemoglobin, and transferrin. Uptake decreased significantly when cells were
exposed with BSA and fetuin, suggesting that fetuin may deter particle uptake.
Finally, particle uptake decreased when calcium was removed from the exposure
media, suggesting that uptake occurs through a calcium dependent process.
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1. INTRODUCTION
The recent growth of products and applications that contain, or utilize,
nanomaterials has occurred in the absence of detailed knowledge of the
interactions of nanoparticles with environmental processes. At the core of this
lack of understanding are the processes by which nanoparticles interact with
biological membranes. While studies have attempted to elucidate the modes by
which particles are endocytosed, no direct mechanistic processes have been
described.
A review of the literature on NP uptake revealed that the vast majority of
the work has been performed using in vitro cell culture assays. Results of the
research efforts to date can be contradictory, as no definitive conclusions have
been agreed on about what particle types result in the greatest degree of uptake
[1,2]. One potential reason for the inconsistencies is the complex cell culture
medium used in the bioassays.

Few, if any, studies have quantified the

interactions of the NP of interest with the components of the medium; in spite of
the fact that several investigators have reported on the role of protein corona
formation on the surfaces of nanoparticles [3,4,5]. Hence, it is critical to better
understand particle-protein interactions and the formation of protein coronas, for
the cell likely recognizes the proteins that readily and rapidly sorb to particle
surfaces due to hydrophobic and electrostatic interactions [6,7,8].
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The challenge in undertaking a study to elucidate which protein
components of a complex culture medium enhance or inhibit nanoparticle uptake
is that there are many combinations to investigate. To reduce the number of
assays I have taken a simplified approach called a protein identification
evaluation (PIE).

This process is similar to that used to identify the toxic

component(s) of complex effluents, through Toxicity Identification Evaluations
(TIEs) [9,10]. The experimental design for my research began with the entire cell
culture medium, and then used physical and chemical separation techniques to
remove certain components. After each separation, another assay is performed
and the effect of the separation on NP uptake is quantified. Additional separation
techniques are then applied to the fractions and bioassays repeated.

After

several iterations the protein(s) remaining in each fraction will be identified.
Using this procedure, it is possible to isolate and identify proteins that enhance or
inhibit NP uptake.
The goal of this research was to identify the components of the cell culture
medium that enhance the cell uptake of gold nanoparticles. Fetal bovine serum
(FBS), a widely used media supplement, contains an array of different proteins,
each of which has the potential to interact with particle surfaces [1]. The affinity of
a given protein to interact with a nanoparticle may be dependent upon the
physical characteristics of that particle [11,12]. As different proteins are known to
enter cells through different mechanisms, an understanding of particle
characteristics, as well as surface-bound proteins, will help to further understand
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the processes by which nanoparticles enter cells [1]. I hypothesize that the
uptake of gold nanospheres by A549 cells is dependent upon the interactions of
the particles with serum supplements in the exposure medium, and these
interactions mediate the transport of particles across membranes.

2. MATERIALS AND METHODS
2.1 Particle Synthesis
Citrate-capped gold nanospheres, 30nm, were produced in-house by
methods previously described [13]. Briefly, particles were synthesized by adding
2.5ml 0.01M HAuCl4 to 100ml ultrapure water while stirring. The solution was
brought to a boil, and a 1% citrate solution was added to the mixture. The
solution was then allowed to stir and continue boiling for 15-20 minutes until the
solution was a deep red.

2.2 Particle Characterization
Particles were characterized in ultra-pure water for size and morphology
using transmission electron microscopy (TEM) techniques (Clemson University
Electron Microscopy Laboratory).

Relative particle sizes were obtained by

dynamic light scattering (DLS), and a measure of the electrokinetic potential
(zeta potential) for each particle type was obtained. DLS and zeta measurements
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were analyzed using a 90Plus Particle Size Analyzer (Brookhaven). Particles
were analyzed after digestion in aqua regia (nitric acid:hydrochloric acid, 1:3
respectively), and dilution to a 5% acid solution. Gold mass was analyzed via
inductively coupled plasma-mass spectrometry (ICP-MS) (Thermo Scientific
XSeries 2).

2.3 Cell Culture
A549 adenocarcinomic human alveolar basal epithelial cells (ATCC,
Rockville MD) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with 4.5 g/l glucose, 584mg/l L-glutamine, and 110mg/l sodium pyruvate
(Mediatech, Inc., Manassas, VA). DMEM was supplemented with 10% fetal
bovine serum (HyClone, Logan, UT), 1% penicillin/streptomycin (HyClone), and
2% non-essential amino acids (Sigma-Aldrich, St. Louis, MO) to form complete
growth medium. Cells were cultured in 75cm2 sterile, polystyrene, tissue culturetreated, vented flasks under clean conditions (Corning, Corning, NY), and
incubated under 5% CO2 at 37°C as described previously [14, 15].
For subculturing, cells in flasks were rinsed with 1X PBS (Fisher Scientific,
Waltham, MA), and incubated in a 0.25% trypsin (Sigma-Aldrich) solution for 515 minutes, or until cells detached from the flask surface. Complete growth
media was then added to inhibit trypsin activity, and cells were aspirated and
transferred to sterile centrifuge tubes (Corning). Cells were centrifuged at 3,000
rpm (1,400 g) for three minutes, after which the supernatant was removed and
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discarded. Cells were then resuspended in complete growth medium, diluted,
and transferred to sterile flasks. When not in use, cells were cryopreserved at -80
°C in complete growth media supplemented with 5% dimethyl sulfoxide (DMSO)
(Fisher Scientific).

2.4 Cell Exposures
Cells were removed from flasks using a 0.25% trypsin solution, and plated
in sterile, polystyrene, tissue culture-treated 12-well plates (Costar, Corning, NY)
at 100,000 cells per well. Cells were plated in complete growth medium and
allowed 24 h for attachment to the plate surface [16].
growth

media

was

aspirated,

and

exposure

After 24 h, complete

medium

containing

gold

nanoparticles was carefully added to each well. Cell viability was examined and
confirmed for each exposure medium using the Promega™ CellTiter 96™
AQueous One Solution Cell Proliferation Assay (MTS) (Fisher Scientific). Viability
was not significantly different from that of controls under any of the conditions
tested.

2.4.1 FBS vs. BSA Supplementation
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with FBS (30.3g/l) and DMEM supplemented with bovine serum
albumin (BSA) (Fisher Scientific). A BSA solution was formulated by diluting BSA
in 1X PBS to a concentration of 22.6g/l, to mimic the average albumin
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concentration of Standard FBS (HyClone Historical Data Sheet, Appendix II).
Complete exposure medium was formulated to contain 1% FBS, 5% FBS, 10%
FBS, 20% FBS, 1% BSA, 5% BSA, 10% BSA, and 20% BSA. Cells were
exposed to 1mg/l gold nanospheres in each exposure medium for 2 h. At the end
of each time-point, exposure medium was removed and cells were carefully
rinsed with 1X PBS to remove residual particles.

2.4.2 Phase I PIE
A Phase I Particle Interaction Evaluation (PIE) was conducted through the
use of different forms of FBS that remove specific components from the serum.
Cells were exposed to increasing concentrations of Standard FBS (FBS)
(30.3g/l), Charcoal/Dextran Treated FBS (cFBS) (25.7g/l), Dialyzed FBS (dFBS)
(29.5 g/l), and Super-Low immunoglobulin G (IgG) FBS (iFBS) (29.9g/l).
Complete exposure medium was formulated to contain 1%, 5%, 10%, and
20% of each type of FBS. Cells were exposed to 1mg/l 30nm citrate-capped gold
nanospheres in each exposure medium for 2 h. At the end of each time-point,
exposure medium was removed and cells were carefully rinsed with 1X PBS to
remove residual particles.
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2.4.3 Phase II PIE
A Phase II Particle Interaction Evaluation (PIE) was conducted through the
addition of FBS components to BSA. Concentrations of each component were
determined from HyClone’s Historical Data Sheet for Standard FBS (Appendix
II). Specifically, a 320mg/l cholesterol-rich apolipoprotein solution was prepared
in BSA (aBSA), an 81mg/l hemoglobin solution was prepared in BSA (hBSA),
and a 1.79 g/l transferrin solution was prepared in BSA (tBSA)by diluting the apotransferrin concentration to 0.38g/l and the holo-transferrin concentration to 1.41
g/l. HyClone’s Historical Data Sheet does not quantify levels of fetuin, however,
based on the average total protein concentration, and protein concentrations
listed, as well as values in the literature, fetuin concentrations were estimated to
be 10g/l [17]. As such, a 10g/l fetuin solution was prepared in BSA (fBSA). All
proteins were purchased from Sigma-Aldrich.
Complete exposure medium was formulated to contain 1%, 5%, 10%, and
20% of BSA, and each protein-BSA complex. Cells were exposed to 1mg/l 30nm
citrate-capped gold nanospheres in each exposure medium for 2 h. At the end of
each time-point, exposure medium was removed and cells were carefully rinsed
with 1X PBS to remove residual particles. Cell viability was examined and
confirmed for each exposure medium using the Promega™ CellTiter 96™
AQueous One Solution Cell Proliferation Assay (MTS) (Fisher Scientific).
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2.4.4 Influence of Calcium
The influence of calcium on particle uptake was examined by exposing
cells to 30nm gold nanospheres in standard DMEM which contains calcium
(200mg/l) (Mediatech), and calcium free DMEM (Invitrogen). Calcium free DMEM
was supplemented with L-glutamine and sodium pyruvate, at concentrations of
584mg/l and 110mg/l, respectively, to mimic complete growth medium
(Invitrogen). Complete exposure medium was formulated to contain 10% FBS in
standard DMEM, 10% FBS in calcium free DMEM, 10% BSA in standard DMEM,
and 10% BSA in calcium free DMEM.

Cells were exposed to 1mg/l gold

nanospheres in each exposure medium for 2 h. At the end of each time-point,
exposure medium was removed and cells were carefully rinsed with 1X PBS to
remove residual particles.

2.5 Analytical Procedure
At the end of each time-point, exposure medium was removed and cells
were carefully rinsed with 1X PBS to remove residual particles. Gold
nanospheres were digested within each well following the addition of 1ml 30%
aqua regia, and plates were incubated at 37°C under 5% CO2 for 30 minutes.
Samples were removed from each well and diluted to a 5% acid solution. Gold
uptake was analyzed via inductively coupled ICP-MS (Thermo Scientific XSeries
2).
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2.6 Data Analysis
Data presented are in a mass-basis format (Au ng/105 Cells) and
represent the average and standard deviation of triplicate samples. All statistical
analysis was performed using SAS and JMP Pro 10 (SAS Institute, Cary, NC,
USA). Statistically significant differences were determined by a t-test and
relationships were determined by simple linear regression. Statistical differences
between relationships were determined by an analysis of covariance (ANCOVA).
A p value less than 0.05 was considered statistically significant.

3. RESULTS AND DISCUSSION
3.1 Particle Characterization
Particles were characterized in ultrapure water by TEM for size and
morphology. Measurements were quantified at random with TEM software, as
well as with ImageJ (National Institutes of Health). Citrate-capped gold
nanoparticles were found to be spherical in shape with a diameter of 30nm
(29.57±8.78) (Appendix I: Image AI-9). DLS estimated that 30nm citrate particles
had a diameter of 36nm (35.74±0.65). Zeta potential measurements were also
quantified and used to predict particle charge and stability in solution.
average

zeta

potential

for

30nm

citrate-capped

spheres

was

The

-45mV

(-45.19±5.87). These results reveal that the particles used in these experiments
were monodispersed and stable in suspension.
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3.2 FBS vs. BSA Supplementation
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of FBS. After 2h, gold uptake in 105
cells was 148.64±39.43ng when exposed in exposure medium containing 1%
FBS, 64.45±9.41ng when exposed in exposure medium containing 5% FBS,
30.01±5.20ng when exposed in exposure medium containing 10% FBS, and
19.04±2.49ng when exposed in exposure medium containing 20% FBS (Figure
3.1). Uptake was negatively correlated to FBS concentration, as uptake
decreased with an increase in protein concentration (R2=0.85, p<0.0001).
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of BSA. After 2h, gold uptake in 105
cells was 119.90±16.59ng when exposed in exposure medium containing 1%
BSA, 129.98±4.48ng when exposed in exposure medium containing 5% BSA,
134.68±9.57ng when exposed in exposure medium containing 10% BSA, and
132.94±5.55ng when exposed in exposure medium containing 20% BSA (Figure
3.2). Regression analysis confirmed that there was no relationship between
nanoparticle uptake and BSA concentration (R2=0.27, p=0.0858).
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Figure 3.1: The influence of FBS on the uptake of gold nanoparticles by A549
Cells.
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Figure 3.2: The influence of BSA on the uptake of gold nanoparticles by A549
Cells.
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3.3 Phase I PIE
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of Super-Low IgG FBS (iFBS).
After 2h, gold uptake in 105 cells was 128.46±13.15ng when exposed in exposure
medium containing 1% iFBS, 72.60±4.27ng when exposed in exposure medium
containing 5% iFBS, 33.94±6.10ng when exposed in exposure medium
containing 10% iFBS, and 21.80±1.68ng when exposed in exposure medium
containing 20% iFBS (Figure 3.3). Uptake was negatively correlated to iFBS
concentration, as uptake decreased with an increase in protein concentration
(R2=0.89, p<0.0001). An analysis of covariance (ANCOVA) was utilized to
examine differences between the uptake of particles exposed in iFBS in
comparison to FBS. There was no statistical difference in the regression slopes
(p=0.4478).
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of Dialyzed FBS (dFBS). After 2h,
gold uptake in 105 cells was 175.66±2.36ng when exposed in exposure medium
containing 1% dFBS, 68.38±13.65ng when exposed in exposure medium
containing 5% dFBS, 48.20±4.50ng when exposed in exposure medium
containing 10% dFBS, and 36.56±7.09ng when exposed in exposure medium
containing 20% dFBS (Figure 3.4). Uptake was negatively correlated to dFBS
concentration, as uptake decreased with an increase in protein concentration
(R2=0.74, p=0.0003). An ANCOVA confirmed that there was no statistical
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Figure 3.3: The influence of FBS on the uptake of gold nanoparticles by A549
Cells, compared to that of iFBS. Statistical analysis revealed that there was no
difference when media was supplemented with iFBS.
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Figure 3.4: The influence of FBS on the uptake of gold nanoparticles by A549
Cells, compared to that of dFBS. Statistical analysis revealed that there was no
difference when media was supplemented with dFBS.
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difference in the regression slopes (p=0.1522) between the uptake of particles in
dFBS and FBS.
Cells were also exposed to 30nm citrate-capped gold nanospheres in
DMEM supplemented with increasing concentrations of Charcoal/Dextran
Treated FBS (cFBS). After 2h, gold uptake in 105 cells was 162.14±32.38ng in
exposure medium containing 1% cFBS, 71.70±12.78ng in exposure medium
containing 5% cFBS, 49.29±10.41ng in exposure medium containing 10% cFBS,
and 45.59±5.95ng in exposure medium containing 20% cFBS (Figure 3.5).
Uptake was negatively correlated to cFBS concentration, as uptake decreased
with an increase in protein concentration (R2=0.63, p=0.0020). An ANCOVA
indicated that there was a statistical difference in the regression slopes
(p=0.0366) between the uptake of particles in cFBS compared to FBS.

3.4 Phase II PIE
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of BSA and cholesterol-rich
apolipoproteins (aBSA). After 2h, gold uptake in 105 cells was 56.86±3.50ng in
exposure medium containing 1% aBSA, 66.56±9.55ng in exposure medium
containing 5% aBSA, 67.74±2.83ng in exposure medium containing 10% aBSA,
and 71.88±10.29ng in exposure medium containing 20% aBSA (Figure 3.6).
Uptake was positively correlated to aBSA concentration, as uptake increased
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Figure 3.5: The influence of FBS on the uptake of gold nanoparticles by A549
Cells, compared to that of cFBS. Statistical analysis revealed that there was a
significant increase in uptake when media was supplemented with cFBS.
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Figure 3.6: The influence of BSA on the uptake of gold nanoparticles by A549
Cells, compared to that of aBSA. Statistical analysis revealed that there was no
difference when media was supplemented with aBSA.
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with an increase in protein concentration (R2=0.36, p=.0404). An analysis of
covariance (ANCOVA) showed there was no statistical difference in the
regression slopes (p=0.6241) between the uptake of particles in aBSA compared
to BSA.
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of BSA and hemoglobin (hBSA).
After 2h, gold uptake in 105 cells was 97.08±3.06ng in exposure medium
containing 1% hBSA, 89.84±4.50ng in exposure medium containing 5% hBSA,
84.98±3.90ng in exposure medium containing 10% hBSA, and 96.14±14.74ng in
exposure medium containing 20% hBSA (Figure 3.7). There was no correlation
between uptake and hBSA concentration, as uptake remained the same as
protein concentrations increased (R2=0.00, p=1.0000). An ANCOVA found there
was no statistical difference in the regression slopes (p=0.1906) between the
uptake of particles in hBSA compared to BSA.
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with increasing concentrations of BSA and transferrin (tBSA). After
2h, gold uptake in 105 cells was 83.16±14.55ng in exposure medium containing
1%

tBSA,

100.14±8.50ng

in

exposure

medium

containing

5%

tBSA,

92.36±5.47ng in exposure medium containing 10% tBSA, and 119.24±11.27ng in
exposure medium containing 20% tBSA (Figure 3.8). Uptake was positively
correlated to tBSA concentration, as uptake increased with an increase in protein
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Figure 3.7: The influence of BSA on the uptake of gold nanoparticles by A549
Cells, compared to that of hBSA. Statistical analysis revealed that there was no
difference when media was supplemented with hBSA.
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Figure 3.8: The influence of BSA on the uptake of gold nanoparticles by A549
Cells, compared to that of tBSA. Statistical analysis revealed that there was no
difference when media was supplemented with tBSA.
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concentration (R2=0.53, p=.0073). An ANCOVA showed that there was no
statistical difference in the regression slopes (p=0.1538) between the uptake of
particles in tBSA and BSA.
Finally, cells were exposed to 30nm citrate-capped gold nanospheres in
DMEM supplemented with increasing concentrations of BSA and fetuin (fBSA).
After 2h, gold uptake in 105 cells was 53.04±2.59ng in exposure medium
containing 1% fBSA, 42.19±0.08ng in exposure medium containing 5% fBSA,
33.85±1.30ng in exposure medium containing 10% fBSA, and 26.29±1.85ng in
exposure medium containing 20% fBSA (Figure 3.9). Uptake was negatively
correlated to fBSA concentration, as uptake decreased with an increase in
protein concentration (R2=0.53, p=.0073). An analysis of covariance (ANCOVA)
indicated that there was a statistical difference in the regression slopes
(p<0.0001) between uptake of particles in fBSA compared to BSA.

3.5 Influence of Calcium
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
containing

calcium

supplemented

10%

FBS,

DMEM

free

of

calcium

supplemented with 10% FBS, DMEM containing calcium supplemented with 10%
BSA, and DMEM free of calcium supplemented with 10% BSA (Figure 3.10).
After 2h, gold uptake in 105 cells was 17.52±0.87ng in exposure medium calcium
with 10% FBS and 13.12±0.82ng in exposure medium free of calcium with 10%
FBS. A t-test was conducted to examine differences in uptake in media
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Figure 3.9: The Influence of BSA on the uptake of gold nanoparticles by A549
Cells, compared to that of fBSA. Statistical analysis revealed that there was a
significant decrease in uptake when media was supplemented with fBSA.
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Figure 3.10: Comparison of calcium dependence on particle uptake at 2 h.
Values with the same letter are not statistically different from each other.
Statistical comparisons between FBS treatments (left) and BSA treatments
(right), while represented together, were conducted independently of each other.

82

supplemented with FBS in the presence and absence of calcium, and found that
uptake significantly decreased when calcium was removed from the system
(p=0.0031).
Gold uptake in 105 cells was 161.22±13.68ng in exposure medium calcium
with 10% BSA and 130.34±9.26ng in exposure medium free of calcium with 10%
BSA. Once again, a t-test showed that uptake significantly decreased when
calcium was removed from the system (p=0.0382). The data further support the
notion that albumin was highly involved in the uptake of 20nm citrate-capped
spheres by A549 cells, while also suggesting that calcium was involved in this
process when exposure medium was supplemented with both FBS and BSA.

4. DISCUSSION
The uptake of gold nanoparticles was inversely related to the
concentration of supplemented FBS. It was first believed that this response was
due to competition for receptor binding sites, and that higher concentrations of
FBS were simply flooding the system with available proteins. However,
examination of exposures supplemented with BSA suggested that competition
was not a likely mechanism, as a similar inverse relationship was not observed.
Albumin accounts for roughly 65% of FBS, by mass, and is by far the most
concentrated component of FBS. As a result of the drastic differences in these
relationships observed, I hypothesized that albumin does not deter the uptake of
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nanoparticles by mammalian cells. Furthermore, the absence of calcium from the
media had a significant effect on particle uptake, suggesting that calcium is
necessary for the transfer of particles across membranes.
A Phase I PIE investigation involved the removal of constituents from the
serum supplement, and examining cellular response. Charcoal/Dextran FBS
removed lipophilic non-polar compounds such as growth factors, hormones,
cytokines and steroids; Dialyzed FBS removed hormones and cytokines; Superlow IgG FBS decreased IgG concentrations from 0.2g/l to less than 0.005g/l. No
significant difference in the uptake of gold nanoparticles was observed following
the reduction of IgG in the supplemented media. Removing hormones and
cytokines from supplemented media through the use of Dialyzed FBS also had
no effect on particle uptake. However, the removal of lipophilic non-polar
components such as steroids, growth factors, hormones and cytokines did have
a significant effect on particle uptake. The removal of these components caused
a significant increase in the uptake of 30nm citrate-capped spheres. As a result, I
suggest that the inhibition is due mainly to growth factors and steroids, as the
removal of hormones and cytokines had no effect in the Dialyzed FBS exposed
treatments.
A Phase II PIE involved the addition of FBS components to bovine serum
albumin, and examining cellular response. In knowing the components that
cause an alteration in cellular response, an understanding of the interactions
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involved in particle uptake, as well as deterrence from uptake, may be gained.
The addition of cholesterol-rich apolipoproteins, hemoglobin, and transferrin,
revealed no significant difference in the regression slope in comparison to
standard BSA. However, the addition of fetuin to BSA, at concentrations intended
to mimic those commonly found in FBS, had a significant negative impact on the
uptake of gold nanoparticles. As a result, I suggest that the deterrence from
particle uptake, observed when cells were exposed in media supplemented with
FBS, is also due to particle interactions with fetuin.
Previous research identified the presence of apolipoproteins and
hemoglobin in protein coronas of nanoparticles, increasing their potential to affect
the intracellular trafficking, fate, and transport of nanoparticles in cells [18].
Furthermore,

current

literature

suggests

that

particles

conjugated

with

apolipoproteins and transferrin facilitates the uptake of nanoparticles to which
they are conjugated [19, 20]. However, other studies indicated that fetuin was
involved in the hepatic uptake of negatively charged particles by rat livers. Fetuin
is highly expressed in hepatocytces and is involved with the regulation of bone
growth, which could explain why a similar response was not observed in lung
cells in my study [21]. This information, coupled with that of my study, suggests
that predictive modeling of particle uptake, based on protein-particle interactions,
cannot be accomplished through the analysis of a single cell line [22].
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While albumin has been shown to interact with various particle types,
results from this study suggest that particles may be interacting with proteins
other than albumin, and that these interactions have a significant impact on
particle uptake [23]. Another possibility is that proteins present in FBS, such as
apolipoproteins, hemoglobin, and transferrin, may be interacting with albumin.
The interactions may decrease the potential for particle-albumin binding,
resulting in a slight decrease in particle uptake. However, the lack of significant
difference

in

the

relationship

of

uptake

collectively

among

different

concentrations leads me to believe these protein-protein interactions do not have
a major impact on particle uptake.
The possibility exists that these results are confounded by overall cell
health through the exposure period. Cells are cultured in FBS in the presence of
nutrients essential to their health, replication, integrity, and survival. However, the
experiments described above were designed to extrapolate the involvement of
specific protein-particle interactions on uptake and involved exposing cells in the
absence of these essential nutrients. While the MTS assay is commonly used to
test for cell viability in in vitro assays, viability is assumed through its measure of
metabolic activity. While exposed cells were not less active in comparison to
controls, there exists the potential that the MTS assay lacked the necessary
accuracy to detect differences in membrane activity during these 2 h exposures
[24]. As a result, alterations in particle uptake may be a function of cells actively
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scavenging for unavailable nutrients that were absent from the exposure
medium.

5. CONCLUSIONS
To understand the mechanisms behind the transfer of particles across
membranes it is necessary to understand the vectors that mediate this process. I
conclude from this study that particle uptake is dependent upon the components
that exist within a given exposure medium. Specifically, protein-particle
interactions, that occur readily and rapidly when in contact with each other,
influence the cellular yield of particle uptake. Fetuin, growth factors, and steroids,
commonly present in exposure mediums of studies involving nanoparticle uptake,
had a negative impact on particle uptake. Because fetuin exists in relatively high
concentrations in FBS, I hypothesize that fetuin may be responsible for the
decrease in uptake observed in exposures in FBS [17]. Furthermore, because
fetuin levels decrease substantially following development, and are lower in
humans than bovines, the current body of in vitro bioassay research that has
been conducted using FBS may be inadequate to predict particle uptake in postfetal, non-bovine biota [17, 25]. However, further research is warranted to better
understand these interactions and their impact on the cellular trafficking of
engineered nanoparticles.
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CHAPTER 4
EXAMINATION OF POTENTIAL MODES OF
NANOPARTICLE UPTAKE THROUGH THE
PHARMACOLOGICAL INHIBITION OF ENDOCYTIC
PATHWAYS

ABSTRACT: This study attempted to assess the modes of endocytosis
involved in the uptake of 30nm citrate-capped gold nanospheres by the
mammalian cell line A549. Cells were pre-incubated for 0.5 h in the presence of
pharmacological inhibitors, after which the exposure medium was spiked with
gold nanoparticles at a final concentration of 1mg/l, and cells were exposed for 1
h. Filipin and nystatin were used to inhibit caveolae-dependent endocytosis,
chlorpromazine and phenylarsine oxide to inhibit clathrin-dependent endocytosis,
and cytochalasin D and 5-(N-ethyl-N-Isopropyl) amiloride (EIPA) were utilized to
inhibit macropinocytosis. No statistical decrease in particle uptake, in comparison
to controls, was observed following exposure to any of the inhibitors. Particle
uptake actually increased significantly when exposed to inhibitors of caveolaedependent endocytosis and macropinocytosis. My data suggest that the uptake
of nanoparticles was not dependent upon any one specific mode of endocytosis.
Furthermore, it is likely that all three modes were utilized in the cellular trafficking
of engineered nanoparticles.
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1. INTRODUCTION
The explosion of products that contain or utilize nanoparticles has
occurred in the absence of detailed knowledge of how these materials will
interact with biological systems. As of 2006, less than 3% of research funding for
the advancement of nanotechnologies was awarded to investigate the health and
safety of these materials, and President Obama requested that 7% be awarded
to this investigation in 2014 [1,2]. Fundamental knowledge concerning how biota
will respond to nanoparticle exposures involves the interactions of these particles
with cell membranes. Currently, research describing the specific mechanisms
involved in the uptake of nanoparticles is lacking.
Previously, research from our lab investigated the role that particle size
and surface charge have on the uptake of gold nanospheres. Gold nanoparticles
were chosen for these studies as they are an ideal model particle due to their
stability and relatively low toxicity [3]. I focused my endeavors on the interactions
between particles and components of supplemented serum in cell growth
medium in an attempt to better understand factors involved in the movement of
particles across membranes. For these studies, 30nm citrate-capped gold
nanospheres were utilized due to their ease of synthesis and the abundance of
research in the scientific community on citrate-capped gold spheres. Our
interests are now focused on how particles cross cell membranes.
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Currently, it has been suggested that nanoparticles may enter cells
through three modes of endocytosis: caveolae-dependent endocytosis, clathrindependent endocytosis, and macropinocytosis. Caveolae-dependent endocytosis
involves the formation of caveolae by the recruitment of caveolin to lipid rafts in
the plasma membrane which are rich in cholesterol and sphingolipids [4].
Clathrin-dependent endocytosis involves the formation of clathrin-coated vesicles
formed by the recruitment of adaptor protein-2 (AP-2) and clathrin to
synaptotagmin rich regions of the plasma membrane [5]. Macropinocytosis
involves the formation of macropinosomes by budding ruffles, or lamellipodia,
constructed by actin polymerization [6].
The goal of my project was to determine the mode(s) by which 30nm
citrate-capped gold nanospheres are endocytosed by mammalian cells. The
analysis was conducted by exposing cells to pharmacological inhibitors of
caveola-dependent

endocytosis,

clathrin-dependent

endocytosis,

and

macropinocytosis, and comparing the degree of particle particle uptake to cells
not exposed to these inhibitors. Understanding how these materials cross
membranes will enhance the development of products relying on particle uptake
for biomedical purposes, while also facilitating future endeavors of accurately
characterizing the risk that these materials may pose to biota and the
environment.
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2. MATERIALS AND METHODS
2.1 Particle Synthesis
Citrate-capped gold nanospheres, 30nm, were produced in-house by
methods previously described [7]. Briefly, particles were synthesized by adding
2.5ml 0.01M HAuCl4 to 100ml ultrapure water while stirring. The solution was
brought to a boil, and a 1% citrate solution was added to the mixture. The
solution was then allowed to stir and continue boiling for 15-20 minutes until the
solution was a deep red.

2.2 Particle Characterization
Particles were characterized in ultra-pure water for size and morphology
using transmission electron microscopy (TEM) techniques (Clemson University
Electron Microscopy Laboratory).

Relative particle sizes were obtained by

dynamic light scattering (DLS), and a measure of the electrokinetic potential
(zeta potential) for each particle type was obtained. DLS and zeta measurements
were analyzed with a 90Plus Particle Size Analyzer (Brookhaven). Particles were
analyzed after digestion in aqua regia (nitric acid:hydrochloric acid, 1:3
respectively), and dilution to a 5% acid solution. Gold mass was analyzed via
ICP-MS (Thermo Scientific XSeries 2).
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2.3 Cell Culture
A549 adenocarcinomic human alveolar basal epithelial cells (ATCC,
Rockville MD) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with 4.5 g/l glucose, 584mg/l L-glutamine, and 110mg/l sodium pyruvate
(Mediatech, Inc., Manassas, VA). DMEM was supplemented with 10% fetal
bovine serum (HyClone, Logan, UT), 1% penicillin/streptomycin (HyClone), and
2% non-essential amino acids (Sigma-Aldrich, St. Louis, MO) to form complete
growth medium. Cells were cultured in 75cm2 sterile, polystyrene, tissue culturetreated, vented flasks under clean conditions (Corning, Corning, NY), and
incubated under 5% CO2 at 37°C as described previously [8, 9].
For subculturing, cells in flasks were rinsed with 1X PBS (Fisher Scientific,
Waltham, MA), and incubated in a 0.25% trypsin (Sigma-Aldrich) solution for 515 minutes, or until cells detached from the flask surface. Complete growth
media was then added to inhibit trypsin activity, and cells were aspirated and
transferred to sterile centrifuge tubes (Corning). Cells were centrifuged at 3,000
rpm (1,400 g) for three minutes, after which the supernatant was removed and
discarded. Cells were then resuspended in complete growth medium, diluted,
and transferred to sterile flasks. When not in use, cells were cryopreserved at -80
°C in complete growth media supplemented with 5% dimethyl sulfoxide (DMSO)
(Fisher Scientific).
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2.4 Cell Exposures
Cells were removed from flasks using a 0.25% trypsin solution, and plated
in sterile, polystyrene, tissue culture-treated 12-well plates (Costar, Corning, NY)
at 100,000 cells per well. Cells were plated in complete growth medium and
allowed 24 h for attachment to the plate surface [10].
growth

media

was

aspirated,

and

exposure

After 24 h, complete

medium

containing

gold

nanoparticles was carefully added to each well.
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with FBS (30.3g/l) and DMEM supplemented with bovine serum
albumin (BSA) (Fisher Scientific) in the presence and absence of known
inhibitors of specific modes of endocytosis. All inhibitors were purchased from
Sigma-Aldrich. A BSA solution was formulated by diluting BSA in 1X PBS to a
concentration of 22.6g/l, to mimic the average albumin concentration of Standard
FBS (HyClone Historical Data Sheet, Appendix II). Cell viability was examined
and confirmed for each exposure medium using the Promega™ CellTiter 96™
AQueous One Solution Cell Proliferation Assay (MTS) (Fisher Scientific). Viability
was not significantly different from that of controls under any of the conditions
tested.
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2.4.1 Inhibition of Caveolae-Dependent Endocytosis
Cells were pre-incubated in exposure medium supplemented with 10%
FBS, 10% BSA, 10% FBS and filipin (1, 5, and 10 mg/l in 1X PBS containing
0.05% DMSO), 10% FBS and nystatin (5, 25, and 50 mg/l in 1X PBS containing
0.05% DMSO), 10% BSA and filipin (1, 5, and 10 mg/l in 1X PBS containing
0.05% DMSO), and 10% BSA and nystatin (5, 25, and 50 mg/l in 1X PBS
containing 0.05% DMSO) for 30 minutes. Each well was spiked with 30nm
citrate-capped gold nanospheres at an exposure concentration of 1mg/l, and
exposed for 1 h.

2.4.2 Inhibition of Clathrin-Dependent Endocytosis
Cells were pre-incubated in exposure medium supplemented with 10%
FBS, 10% BSA, 10% FBS and chlorpromazine (0.5, 2.5, and 5 mg/l in 1X PBS),
10% FBS and phenylarsine oxide (5, 25, and 50 µg/l in 1X PBS containing 0.05%
DMSO), 10% BSA and chlorpromazine (0.5, 2.5, and 5 mg/l in 1X PBS), and
10% BSA and phenylarsine oxide (5, 25, and 50 µg/l in 1X PBS containing 0.05%
DMSO) for 30 minutes. Each well was spiked with 30nm citrate-capped gold
nanospheres at an exposure concentration of 1mg/l, and exposed for 1 h.

2.4.3 Inhibition of Macropinocytosis
Cells were pre-incubated in exposure medium supplemented with 10%
FBS, 10% BSA, 10% FBS and cytochalasin D (0.5, 2.5, and 5 mg/l in 1X PBS

99

containing 0.05% DMSO), 10% FBS and 5-(N-ethyl-N-Isopropyl) amiloride
(EIPA) (1, 5, and 10 mg/l in 1X PBS containing 0.05% DMSO), 10% BSA and
cytochalasin D (0.5, 2.5, and 5 mg/l in 1X PBS containing 0.05% DMSO), and
10% BSA and EIPA (1, 5, and 10 mg/l in 1X PBS containing 0.05% DMSO) for
30 minutes. Each well was spiked with 30nm citrate-capped gold nanospheres at
an exposure concentration of 1mg/l, and exposed for 1 h.

2.5 Analytical Procedure
At the end of each time-point, exposure medium was removed and cells
were carefully rinsed with 1X PBS to remove residual particles. Gold
nanospheres were digested within each well following the addition of 1ml 30%
aqua regia, and plates were incubated at 37°C under 5% CO2 for 30 minutes.
Samples were removed from each well and diluted to a 5% acid solution. Gold
uptake was analyzed via ICP-MS (Thermo Scientific XSeries 2).

2.6 Data Analysis
Data presented are in a mass-basis format (Au ng/105 Cells) and
represent the average and standard deviation of triplicate samples. All statistical
analysis was performed using SAS and JMP Pro 10 (SAS Institute, Cary, NC,
USA). Statistically significant differences were determined by a one way analysis
of variance (ANOVA) with Dunnett’s means comparisons test. A p value less
than 0.05 was considered statistically significant.
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3. RESULTS
3.1 Particle Characterization
Particles were characterized by TEM for size and morphology.
Measurements were quantified at random with TEM software, as well as with
ImageJ (National Institutes of Health). Citrate-capped gold nanoparticles were
found to be spherical in shape with a diameter of 30nm (28.73±6.64) (Appendix I:
Image AI-10). DLS estimated that 30nm citrate particles had a diameter of 26nm
(26.06±0.34). Zeta potential measurements were also quantified and used to
predict particle charge and stability in solution. The average zeta potential for
30nm citrate-capped spheres was -50mV (-50.11±8.03). These results reveal
that the particles used in these experiments were monodispersed and stable in
suspension.

3.2 Inhibition of Caveolae-Dependent Endocytosis
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with 10% FBS, and 10% FBS with increasing concentrations of
filipin and nystatin (Figure 4.1). After 1h, gold uptake in 105 cells was
17.63±6.96ng when exposed in exposure medium containing 10% FBS. Gold
uptake was 32.00±2.93ng in exposure medium containing 10% FBS and 1mg/l
filipin, 25.63±2.74ng in exposure medium containing 10% FBS and 5mg/l filipin,
and 30.43±1.18ng in exposure medium containing 10% FBS and 10mg/l filipin.
Gold uptake was 21.30±0.73ng in exposure medium containing 10% FBS and
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Figure 4.1: Uptake of 30nm citrate-capped spheres when exposed in 10% FBS in
the presence of filipin and nystatin (mean ± standard deviation, n=3).
Concentrations with an asterisk are significantly different than that of the controls.
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5mg/l nystatin, 22.33±3.84ng in exposure medium containing 10% FBS and
25mg/l nystatin, and 25.98±2.13ng in exposure medium containing 10% FBS and
50mg/l nystatin.
An analysis of variance (ANOVA) with Dunnett’s means comparisons test
was utilized to analyze differences between cells exposed to each chemical
inhibitor concentration in relation to cells that were not exposed.

Uptake

increased significantly when cells were exposed to 30nm citrate-capped spheres
in the presence of 1mg/l and 10mg/l filipin (p=0.0054 and p=0.0015,
respectively), but not when exposed to 5mg/l filipin (p=0.1175). Cells showed no
significant difference in uptake when exposed to 30nm citrate-capped spheres in
the presence of 5mg/l, 25mg/l, and 50mg/l nystatin (p=0.6522, p=0.4749, and
p=0.1031, respectively).
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with 10% BSA as controls, and 10% BSA with increasing
concentrations of filipin and nystatin (Figure 4.2). After 1h, gold uptake in 105
cells was 81.00±17.56ng when exposed to medium containing 10% BSA. Gold
uptake was 92.30±1.08ng when exposed to medium containing 10% BSA and
1mg/l filipin, 76.42±5.08ng when exposed to medium containing 10% BSA and
5mg/l filipin, and 70.70±1.98ng when exposed to medium containing 10% BSA
and 10mg/l filipin. Gold uptake was 107.32±5.42ng when exposed to medium
containing 10% BSA and 5mg/l nystatin, 90.82±5.15ng when exposed to medium

103

Figure 4.2: Uptake of 30nm citrate-capped spheres when exposed in 10% BSA in
the presence of filipin and nystatin (mean ± standard deviation, n=3).
Concentrations with an asterisk are significantly different than that of the controls.
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containing 10% BSA and 25mg/l nystatin, and 101.68±7.02ng when exposed to
medium containing 10% BSA and 50mg/l nystatin.
An ANOVA with Dunnett’s means comparisons test revealed no significant
difference in the uptake of 30nm citrate-capped spheres when exposed to 1mg/l,
5mg/l and 10mg/l filipin compared to control values (p=0.4679, p=0.9211, and
p=0.5378, respectively). Uptake increased significantly when cells were exposed
to 30nm citrate-capped spheres in the presence of 5mg/l nystatin (p=0.0357), but
not when exposed to 25mg/l or 50mg/l nystatin (p=0.6042 and p=0.1056,
respectively).

3.3 Inhibition of Clathrin-Dependent Endocytosis
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with 10% FBS as controls, and 10% FBS with increasing
concentrations of chlorpromazine and phenylarsine oxide (Figure 4.3). After 1h,
gold uptake in 105 cells was 24.17±6.72ng in medium containing 10% FBS. Gold
uptake was 25.70±3.28ng

in medium containing 10% FBS and 0.5mg/l

chlorpromazine, 20.28±3.04ng in medium containing 10% FBS and 2.5mg/l
chlorpromazine, and 22.97±2.41ng in medium containing 10% FBS and 5mg/l
chlorpromazine. Gold uptake was 23.11±2.75ng in medium containing 10% FBS
and 5µg/l phenylarsine oxide, 22.15±2.68ng in medium containing 10% FBS and
25µg/l phenylarsine oxide, and 25.88±2.78ng in medium containing 10% FBS
and 50µg/l phenylarsine oxide.
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Figure 4.3: Uptake of 30nm citrate-capped spheres when exposed in 10% FBS in
the presence of chlorpromazine and phenylarsine oxide (mean ± standard
deviation, n=3). Concentrations with an asterisk are significantly different than
that of the controls.
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An ANOVA with Dunnett’s means comparisons test revealed no significant
difference in the uptake of 30nm citrate-capped spheres when exposed to
0.5mg/l, 2.5mg/l and 5mg/l chlorpromazine compared to control values
(p=0.9555, p=0.6078, and p=0.9781, respectively). Also, there was no significant
difference in the uptake of 30nm citrate-capped spheres when exposed to 5µg/l,
25µg/l, and 50µg/l phenylarsine oxide compared to control values (p=0.9842,
p=0.9058, and p=0.9380, respectively).
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with 10% BSA as controls, and 10% BSA with increasing
concentrations of chlorpromazine and phenylarsine oxide (Figure 4.4). After 1h,
gold uptake in 105 cells was 110.96±37.55ng in medium containing 10% BSA.
Gold uptake was 90.28±2.94ng in medium containing 10% BSA and 0.5mg/l
chlorpromazine,

98.98±9.94ng

in

containing

10%

BSA

and

2.5mg/l

chlorpromazine, and 99.84±8.38ng in medium containing 10% BSA and 5mg/l
chlorpromazine. Gold uptake was 81.66±4.01ng in medium containing 10% BSA
and 5µg/l phenylarsine oxide, 75.96±4.78ng in medium containing 10% BSA and
25µg/l phenylarsine oxide, and 103.38±3.41ng in medium containing 10% BSA
and 50µg/l phenylarsine oxide.
An ANOVA with Dunnett’s means comparisons test revealed no significant
difference in the uptake of 30nm citrate-capped spheres when exposed to
0.5mg/l,

2.5mg/l and 5mg/l chlorpromazine compared to control values

(p=0.5873, p=0.8702, and p=0.8921, respectively). Also, there was no significant
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Figure 4.4: Uptake of 30nm citrate-capped spheres when exposed in 10% BSA in
the presence of chlorpromazine and phenylarsine oxide (mean ± standard
deviation, n=3). Concentrations with an asterisk are significantly different than
that of the controls.
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difference in the uptake of 30nm citrate-capped spheres when exposed to 5µg/l,
25µg/l, and 50µg/l phenylarsine oxide compared to control values (p=0.3127,
p=0.1945, and p=0.9590, respectively).

3.4 Inhibition of Macropinocytosis
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with 10% FBS as controls, and 10% FBS with increasing
concentrations of cytochalasin D and EIPA (Figure 4.5). After 1h, gold uptake in
105 cells was 13.46±2.25ng in exposure medium containing 10% FBS. Gold
uptake was 20.41±4.80ng in exposure medium containing 10% FBS and 0.5mg/l
cytochalasin D, 20.94±1.70ng in exposure medium containing 10% FBS and
2.5mg/l cytochalasin D, and 26.99±2.59ng in exposure medium containing 10%
FBS and 5mg/l cytochalasin D. Gold uptake was 23.24±2.34ng in exposure
medium containing 10% FBS and 1mg/l EIPA, 20.24±1.19ng in exposure
medium containing 10% FBS and 5mg/l EIPA, and 20.27±1.31ng in exposure
medium containing 10% FBS and 10mg/l EIPA.
An ANOVA with Dunnett’s means comparisons test revealed a significant
increase in the uptake of 30nm citrate-capped spheres when exposed to 0.5mg/l,
2.5mg/l and 5mg/l cytochalasin D compared to control values (p=0.0157,
p=0.0099, and p=0.0001, respectively). Also, there was a significant increase in
the uptake of 30nm citrate-capped spheres when exposed to 1mg/l, 5mg/l, and
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Figure 4.5: Uptake of 30nm citrate-capped spheres when exposed in 10% FBS in
the presence of cytochalasin D and EIPA (mean ± standard deviation, n=3).
Concentrations with an asterisk are significantly different than that of the controls.
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10mg/l EIPA compared to control values (p<0.0001, p=0.0014, and p=0.0013,
respectively).
Cells were exposed to 30nm citrate-capped gold nanospheres in DMEM
supplemented with 10% BSA as controls, and 10% BSA with increasing
concentrations of cytochalasin D and EIPA (Figure 4.6). After 1h, gold uptake in
105 cells was 70.32±2.92ng in exposure medium containing 10% BSA. Gold
uptake was 110.94±5.00ng in exposure medium containing 10% BSA and
0.5mg/l cytochalasin D, 107.42±10.23ng in exposure medium containing 10%
BSA and 2.5mg/l cytochalasin D, and 133.82±13.41ng in exposure medium
containing 10% BSA and 5mg/l cytochalasin D. Gold uptake was 73.54±42.32ng
in exposure medium containing 10% BSA and 1mg/l EIPA, 96.32±9.69ng in
exposure medium containing 10% BSA and 5mg/l EIPA, and 114.50±13.11ng in
exposure medium containing 10% BSA and 10mg/l EIPA.
An ANOVA with Dunnett’s means comparisons test revealed a significant
increase in the uptake of 30nm citrate-capped spheres when exposed to 0.5mg/l,
2.5mg/l and 5mg/l cytochalasin D compared to control values (p<0.0001,
p<0.0001, and p<0.0001, respectively). Also, there was a significant increase in
the uptake of 30nm citrate-capped spheres when exposed to 10mg/l EIPA
(p=0.0225) compared to control values, but not when exposed to 1mg/l and 5mg/l
EIPA (p=0.9923 and p=0.2100, respectively).
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Figure 4.6: Uptake of 30nm citrate-capped spheres when exposed in 10% BSA in
the presence of cytochalasin D and EIPA (mean ± standard deviation, n=3).
Concentrations with an asterisk are significantly different than that of the controls.
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4. DISCUSSION
Filipin and nystatin are sterol-binding agents that inhibit caveolaedependent endocytosis through the depletion of cholesterol from the plasma
membrane, which is required to maintain the structural integrity of the caveolae
[11]. Following co-exposure with filipin or nystatin and gold nanoparticles, the
uptake of gold did not significantly decrease in comparison to those not treated
with inhibitors, which suggests that uptake does not occur through a caveolaedependent process. Uptake actually increased significantly when cells were
exposed to particles in the presence of filipin when the media was supplemented
with FBS, and increased significantly when cells were exposed to particles in the
presence of nystatin when media was supplemented with BSA. An increase in
uptake in the presence of these inhibitors suggests that exocytosis of these
particles may be cholesterol-dependent, as Dombu et al. [12] observed an
increase in particle uptake in airway epithelium cells when cholesterol was
depleted by filipin and nystatin.
Chlorpromazine

and

phenylarsine

oxide

inhibit

clathrin-dependent

endocytosis by reacting with vicinal sulfhydryls to form stable ring structures and
associating with AP-2, thus removing coated pits from the plasma membrane
[13]. The treatment of cells with chlorpromazine and phenylarsine oxide had no
effect on the uptake of gold nanoparticles when the exposure medium was
supplemented with FBS or BSA, which suggests that the uptake of 30nm citrate-
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capped spheres does not occur through a clathrin-dependent process in A549
cells.
Cytochalasin D and EIPA inhibit macropinocytosis though inhibiting
sodium-proton exchange and the depolymerization of actin, both required for
membrane ruffling and macropinosome formation [14,15]. Exposing cells to these
inhibitors in the presence of gold nanoparticles resulted in significant increases in
uptake when exposed in medium containing FBS as well as BSA. If
macropinocytosis was a mode of uptake of 30nm citrate-capped spheres, a
decrease in uptake in comparison to controls would have been expected. As a
result, I do not believe that macropinocytosis is a major route by which these
particles enter cells. The observed increase in uptake, in the presence of these
inhibitors, suggests that exocytosis of these particles may also be actindependent [16].
Huang et al. [17] examined the uptake of FITC-chitosan nanoparticles by
A549 cells and uptake was inhibited by chlorpromazine, suggesting clathrindependent endocytosis as a possibly mode of uptake. Mo and Lim [18] examined
the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles, once again
by A549 cells, and observed a decrease in particle uptake when exposed to
filipin, suggesting caveolae-dependent endocytosis as a possible mode of
uptake. dos Santos et al. [19] reported that the uptake of polystyrene
nanoparticles was inhibited by cytochalasin A and nocodazole, but not by
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chlorpromazine or genistein in A549 cells, suggesting macropinocytosis as a
possible mode of uptake. Finally, Brandenberger et al. [20] investigated the
uptake of 15nm citrate-capped gold nanospheres, and while inhibition of
caveolae-dependent and clathrin-dependent resulted in a decrease in particle
uptake, TEM data revealed that particles were in large intracellular vesicles,
suggesting uptake by macropinocytosis.
These four studies examined potential modes of uptake in the same cell
line as that of my analysis. While I was not able to pinpoint one direct mode of
uptake, it is apparent that all three modes have been implicated for involvement
in the uptake of nanoparticles. It is likely that cells actually utilize all three modes
of endocytosis in particle uptake, and particles enter through non-specific
mechanisms [21]. Furthermore, the increased degree of particle uptake when
exposed to inhibitors of caveolae-dependent and macropinocytosis may have
been a compensatory response to the blockage or preferred routes of uptake;
however validation of this hypothesized response requires additional evaluation.

5. CONCLUSIONS
I conclude that the uptake of nanoparticles is not dependent upon any one
specific mode of endocytosis. Current literature suggests modes of uptake may
change for differing particle types and cell types; or, as Brandenberger et al. [20]
suggested, include all three of the modes discussed here. Furthermore, my data
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suggest that research into the uptake of 30nm citrate-capped spheres requires
the use of tools other than just pharmaceutical inhibitors.
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CHAPTER 5
CONCLUSIONS AND FUTURE RESEARCH

This study investigated the influence on particle characteristics and media
composition on the uptake of gold nanoparticles attempted to elucidate the
modes by which particles are endocytosed. From the results of this study, we
conclude the following:
1. The uptake of gold nanoparticles by A549 cells is dependent upon
both particle size and particle surface chemistry.


With the exception of 55nm PEG-coated particles, uptake
was greatest with cationic particles, followed by anionic
particles, and nonionic particles.



Uptake was greatest with larger anionic and nonionic
particles but with smaller cationic particles.

2. The uptake of gold nanoparticles by A549 cells is dependent upon
the composition of the medium in which they are exposed.


The removal of steroids and growth factors in supplemented
serum had a positive effect on particle uptake, suggesting
these components deter uptake.
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The addition of fetuin to media supplemented with albumin
had a negative effect on particle uptake, suggesting fetuin
deters particle uptake.



The removal of calcium from the media had a negative
impact on particle uptake, suggesting particle uptake is
calcium dependent.

3. The modes of gold nanoparticle uptake by A549 cells cannot be
determined through the use of pharmacological inhibitors alone.


Exposures to known inhibitors of caveolae-dependent
endocytosis,

clathrin-dependent

endocytosis,

and

macropinocytosis did not have impact on particle uptake,
suggesting no single pathway is utilized.
In order to accurately predict particle uptake based on particle
characteristics, future research will need to include additional factors than those
included in this work. These efforts will need to include more particle sizes, more
particle shapes, and more particle surface chemistry modifications, as more
parameters will strengthen potential uptake models. Particle sizes greater than
50nm and smaller than 5nm must be included, and multiple ligand attachments
for any given charge must also be examined, as different ligands of the same
charge may result in uptake differences. While gold nanoparticles serve as great
model particles for uptake studies, due to their low toxicity, particles of other core
chemistries must also be examined to ensure elemental composition does not
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affect uptake. The impacts of these characteristics must also be examined on a
wide range of cell lines, as no one line can predict particle uptake for all
mammalian cell types. Finally, whole organisms, such as rats and mice, would
need to be utilized to test the accuracy of model predictions based upon in vitro
results.
To better understand the protein-particle interactions involved in the
uptake of nanoparticles, extensions to this work may also be performed. In
examining a Phase I PIE, we relied on a variety of FBS types that were
purchasable from scientific suppliers. As standard FBS is fairly

well

characterized, future researchers could formulate specific FBS compositions that
exclude any one component or class of components, as well as to employ other
methods of component removal from standard FBS. In our examination of a
Phase II PIE, we relied on the addition of the most concentrated proteins, other
than albumin, to solutions of BSA that mimicked albumin concentrations in
standard FBS. Future research should examine the additions of less
concentrated proteins to BSA, as well as examine specific serum proteins alone
in the absence of BSA. This information would directly investigate the roles of
single proteins, and reduce variability of interactions between these proteins, as
well as particles, with albumin. Finally, this area of research would benefit from
future endeavors to examine the affinities of protein-particle interactions to
determine the proteins found in FBS that particles most likely associate with.
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To accurately determine the processes by which nanoparticles enter cells,
future research will need to utilize a variety of tools and not simply rely on mere
pharmacological inhibition. Transmission electron microscopy, environmental
scanning electron microscopy, and light microscopy may prove useful in
depicting actions taking place on the plasma membrane, as well as vesicles
utilized in the storage of nanoparticles once they enter the cell. Futhermore, the
use of small interfering RNA (siRNA) may be a more accurate tool in suppressing
modes of endocytosis in comparison to chemical inhibition. Chemical inhibitors
have to potential to impact various pathways involved in the cell cycle, other than
just endocytosis, while siRNAs are designed to decrease the expression of
specific genes, resulting in the inhibition of specific pathways. As a result, the use
of these techniques would help to validate how particles enter cells.
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APPENDIX I
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Image AI-1: TEM analysis of 5nm citrate-capped spheres
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Image AI-2: TEM analysis of 18nm citrate-capped spheres
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Image AI-3: TEM analysis of 50nm citrate-capped spheres
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Image AI-4: TEM analysis of 6nm PEG-capped spheres
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Image AI-5: TEM analysis of 15nm PEG-capped spheres
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Image AI-6: TEM analysis of 55nm PEG-capped spheres
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Image AI-7: TEM analysis of 5nm PEI-capped spheres
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Image AI-8: TEM analysis of 13nm PEI-capped spheres
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Image AI-9: TEM analysis of 30nm citrate-capped spheres
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Image AI-10: TEM analysis of 30nm citrate-capped spheres
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APPENDIX II
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Table AII-1: Hyclone Historical Data Sheet: Characterization of Standard FBS
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